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CaM                             calmodulin
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GST                              glutathione S-transferase
HPLC                            high pressure liquid chromatography
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IC50                      concentration of inhibitor required for 50% inhibition
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NMR                             nuclear magnetic resonance
PBS                               phosphate buffered saline
PDB                               protein data bank
RNA                              ribonucleic acid
RT                                 room temperature
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Abstract
Dynamic combinatorial chemistry (DCC) is a novel approach to medicinal chemistry
which integrates the synthesis and screening of small molecule libraries into a single
step. The concept uses reversible chemical reactions to present a dynamic library of
candidate structures to a template which selects and removes the best binder from
equilibrium. Using this evolutionary process with a biopolymer template, such as a
protein, leads to the protein directing the synthesis of its own best ligand. Biological
DCC applications are extremely challenging since the thermodynamic criterion of
reversibility has to be met under physiological conditions to ensure stability of the
biomolecular template. The list of reversible reactions satisfying these stringent
criteria is limited and is a major constraint on achieving both reaction and structural
diversity in adaptive dynamic libraries. This thesis reports the development of a
catalysed version of acylhydrazone dynamic libraries which are truly adaptive under
protein-friendly conditions.
In the presence of aniline as a trans-imination catalyst, acylhydrazone dynamic
combinatorial libraries equilibrate rapidly at pH 6.2 and are switched off by an
increase in pH. We designed acylhydrazone libraries targeting the enzyme
superfamily Glutathione-S-Transferase (GST) using a scaffold aldehyde, 4-chloro-3-
nitrobenzaldehyde, which is structurally related to a known GST substrate
chlorodinitrobenzene. On interfacing these dynamic libraries with two different GST
enzymes (SjGST from the helminth worm Schistosoma japonicum and hGSTP1-1, a
human isoform and an important oncology drug target) we observed isoform-
selective amplification effects with two different acylhydrazones selected by the
proteins. To explore the potential of anchoring in our DCC methodology we
conjugated the endogenous GST ligand, glutathione (GSH) onto the scaffold
chloronitrobenzaldehyde. The GSH recognition motif acts as an anchor and allows us
to explore the hydrophobic binding site of the enzyme in a fragment- based
approach. The presence of the glutathione moiety led to increased solubility of the
library members and a DCC experiment with the enzymes led to the selection of
conjugate hydrazones with significant binding ability.
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Multi-level dynamic libraries use multiple exchange processes in the same system to
increase their accessible structural diversity. These exchange reactions may be
orthogonal, where the different chemistries can be activated or deactivated
independently of each other, or simultaneous, where all the processes are dynamic
and crossover under the same conditions. Together, these interacting molecular
networks provide an exciting experimental approach to the emerging field of systems
chemistry. We demonstrate that two reversible reactions, conjugate addition of thiols
to enones and hydrazone formation, are fully compatible and orthogonal to one
another in a single dynamic library. Hydrazone exchange takes place at acidic pH,
while conjugate addition operates at basic pH. Simple pH change can be used to






Over the past century synthetic organic chemistry has evolved into a highly mature
field with tremendous success in building complex molecular structures, usually in a
stepwise fashion. This progress has been aided by an ever-expanding tool-kit of
reactions, a vast majority of which operate under kinetic control. These irreversible
reactions lead to the formation of stable covalent bonds with fast reaction times and
high selectivities. The products of these reactions are determined by the free energy
differences among all possible transition states and thus can be controlled by
appropriate choice of reaction conditions including catalysts. However, over the past
two decades, there has been a renewed interest in chemical reactions carried out
reversibly under equilibrium control which led to the emergence of a new discipline:
dynamic combinatorial chemistry (DCC).1,2 This nascent field borrows heavily from
supramolecular chemistry and self-assembly and has benefited from the sustained
efforts of many well-known research groups throughout the world but the basic
conceptual framework was initially established by exemplary work from Lehn and
Sanders. 3,4
Synthetic processes involving DCC combine the robustness of covalent synthesis
with the unique features of ‘error-checking’ and ‘proof reading’ derived from
reversibility.1 In these systems product formation is under thermodynamic control
and the final product distribution at equilibrium depends on the relative ground-state
stabilities of the product structures. A very significant advantage of dynamic
combinatorial chemistry over the kinetic regime lies in its adaptability: the ability to
re-adjust the product distribution as a response to changes in the reaction
environment (for example, concentration changes, template effects, pH or
temperature) even after the initial products have been formed. These features of DCC
have led to applications in a diverse set of areas ranging from materials science
(dynamic polymers or dynamers)5 to sensors6 and systems chemistry.7  But the most
interesting application of this concept is in drug discovery using nucleic acids or
proteins as templates to bias a dynamic combinatorial library (DCL) thus identifying
best binding compounds for these drug targets.8 Though some preliminary
publications have appeared in this area, challenges remain, especially in the use of
16
proteins as templates.2 Our efforts at meeting some of these challenges form the
central theme of this thesis. In the following sections of this introductory chapter we
review the design of a DCC experiment and previous literature on the application of
DCC and related kinetic approaches to protein targets.
1.2 The design of a DCC experiment
The basic structure of a DCC experiment consists of a library of building blocks
which undergo a reversible reaction to generate a molecular population of great
diversity at equilibrium.1,2 A schematic representation of the DCC concept is given in
Figure 1.1. Under the particular conditions of the experiment, the composition of the
library at equilibrium is determined by the thermodynamic stability of each of the
library members.  A selection mechanism to bias the library is then implemented
which will usually be an added template but may also include other mechanisms (for
example, self-selection, physical properties or a phase selection like binding to a
target on a solid phase or crystallization).2









Figure 1.1 The basic structure of a DCC experiment
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When a template binds tightly to a specific library member, this species is stabilized,
usually through non-covalent interactions, and the equilibrium would shift resulting
in a higher concentration of the selected member. This relative increase in the
concentration of the selected library member is referred to as ‘amplification’ which
can easily be identified by HPLC or LC/MS. Analytical techniques based on
separation usually require a ‘lock-in’ step to fix library composition but can be
avoided in the case of in situ techniques like NMR or X-ray crystallography.2
The key factor responsible for a successful DCC experiment is the choice of the
reversible reaction that mediates the exchange of building blocks between the library
members.1-4 An ideal reaction should be reversible on a reasonable timescale under
mild conditions and should not interfere with the molecular recognition involved in
the selection process. The equilibration rate should be slower than binding with the
target. It should also be possible to kinetically freeze the reaction by suitably
changing experimental conditions like pH or temperature which helps in the analysis
of the DCL composition. The library members synthesized through such a reaction
should be soluble at equilibrium; insoluble members can act as thermodynamic or
kinetic traps which affect the dynamic nature of the system.1
Both covalent and non-covalent bonds (including metal coordination and hydrogen
bonds) are useful in dynamic combinatorial chemistry.1,2 The non-covalent bonds are
usually weak and labile leading to fast equilibration times but low thermodynamic
stability of the products present analytical difficulties. On the other hand, reversible
covalent reactions are slower but form thermodynamically stable products which are
usually robust enough for analysis. Examples of reversible reactions used in DCC are
listed. (Scheme 1.1)
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Scheme 1.1 Some reversible reactions useful for DCC
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For generating an efficient dynamic combinatorial system the building blocks need to
satisfy a few important conditions.1,2 They should possess appropriate functional
groups that take part in the selected reversible reaction. These groups should not
interfere with the molecular recognition event during the selection process.
Additional solubilising groups or chromophores may be incorporated into the
scaffold structure.  Ideally all the building blocks should have similar reactivity in
order to generate an isoenergetic library which prevents bias towards some
components. This condition is practically difficult to meet, given the requirement for
generating maximum structural diversity with minimum number of components. A
near-isoenergetic library can be generated in some cases by suitably selecting the
building block stoichiometry. It is normally expected that the addition of a template
to an equilibrating library would selectively amplify the best binding compound but
this may not necessarily be the case. Since DCLs tend to lower the overall Gibbs free
energy of the system, more than one species may be amplified in some cases. In
some other cases the final equilibrium may even favour library members other than
the thermodynamically most stable one. Generally, it is possible to optimize
experimental conditions to drive the equilibrium exclusively towards the best binding
species.
1.3 Protein-directed dynamic combinatorial chemistry
The use of proteins as templates for small molecule DCLs provides a new method for
studying protein-ligand interactions.2 In the DCC process the structure of the protein
directs the assembly of its best binder in situ thereby combining the synthesis and
biological screening of the candidate structures into a single step. In principle this
concept is a simple one with the template protein stabilizing one member of the DCL
through selective binding and Le Chatelier’s principle ensuring its amplification at
the expense of other non-binding species. But there are several challenges associated
with protein-templated DCC. Most proteins are very sensitive to pH, temperature and
a host of chemical reagents. This requires the DCLs to be assembled under strictly
physiological conditions which place a severe restraint on the reversible synthetic
20
chemistry that can be used. Many innovative approaches have been tried to address
these issues which are discussed in the following sections with specific examples.
1.3.1 C=N Bond Formation
The first example of using DCC with proteins was reported by Huc and Lehn in
1997.3,9 They generated an imine DCL with a set of 3 aldehydes 1-3 and 4 amines
 a-d targeting the enzyme bovine carbonic anhydrase II (CA II), a well-characterised
Zn (II) metalloenzyme (Figure 1.2). The library components were selected to present
structural features similar to those of known CA (II) inhibitors with the 3 aldehydes
containing a para-substituted sulfonamide motif whose nitrogen atom coordinates to
the Zn (II) ion in the enzyme’s active site. Substituents at para- position to the
sulfonamide group interact with a hydrophobic region of the protein above the Zn
(II) pocket. In order to generate isoenergetic libraries components with comparable
imine-forming reactivity were selected while ensuring activity in the UV-visible
spectrum to aid detection and analysis by HPLC.
The DCL was synthesized using a 15-fold excess of amines with respect to each
aldehyde scaffold in phosphate buffer (pH 6) in the presence of 3-fold excess of
NaBH3CN. The excess amounts of starting primary amines were used to limit side
reactions between the aldehydes and the product secondary amines or amino groups
of the protein. CA has 18 Lys ε-NH3+ groups in addition to the terminal amine. The
pseudo-first order conditions established for each aldehyde with every primary amine
ensured that there would be no shortage of any amine which could introduce a bias in
the library composition. The reducing agent irreversibly reduces the highly unstable

































































































a b c d
1 1' 1a 1b 1c 1d
2 2' 2a 2b 2c 2d
3 3' 3a 3b 3c 3d
Figure 1.2 Lehn and Huc’s imine DCL for carbonic anhydrase inhibition
However, a significant drawback of this procedure is that the imine molecules taking
part in the molecular recognition events involving the protein are not represented in
the final analysis of the DCL. Yet another complicating factor is the possible
22
decrease in the aldehyde concentration available for imine formation due to its
reduction to benzylic alcohols 1’-3’ as side products.
Figure 1.3 HPLC traces of the reduced imine DCL. Trace A shows the blank DCL
composition. Trace B shows the DCl generated in the presence of stoichiometric
amounts of the enzyme CA. Amine 3c(++) has been amplified at the expense of 3a
and 3d(-). Amine 3b is relatively unchanged. Reproduced from reference 3.
A blank DCL as a control was first generated in the absence of the CA template. All
the expected imine reduction products were observed in the HPLC trace (Figure 1.3)
with equilibrium attained in 24 hours. However, 2 weeks were required for
equilibration in the presence of the target protein. A thermal denaturation step was
performed to ensure the release of ligands from the enzyme active site. Separation of
the denatured enzyme from the reaction products by microcentrifuge filtration
preceded HPLC analysis. The templated library composition revealed a number of
changes relative to the blank with respect to each set of amines. Overall yields for all
reduction products in the presence of the enzyme were lower than the blank.  The
relative composition of amines derived from aldehydes 1 and 2 were essentially
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unchanged but the amount of amines based on the aldehyde scaffold 3 had undergone
a change in the presence of the protein. An amplification of the benzylamine
derivative 3c was observed at the expense of 3a and 3d while amine 3b maintained
the same relative concentration. A binding series was established by carrying out
similar DCL experiments with 4 amines and aldehyde 3 alone.  A control DCL
synthesized in the presence of a known inhibitor of CA, hexyl 4-sulfamoyl-benzoate,
yielded no amplifications indicating that the active site of the protein was responsible
for the template effect. The imine precursor of the best binder 3c selected by the
protein is very similar in structure to a known high affinity ligand for CA, 4-
sulfamoylbenzoic acid benzylamide (Kd = 1.1 nM). This seminal work by Lehn and
Huc established the basic protocol for the construction of imine DCLs targeting
biomolecules.
Acyl hydrazone formation for DCL generation in the presence of biological targets
was examined by the same research group.10 The Sanders group had previously used
this reaction under thermodynamic control in abiotic systems.11 The reaction
involves aldehyde and hydrazide components forming stable acylhydrazones
amenable to analysis. However, a limitation of the reaction for its use with
biomolecules is the acidic pH (ca. 4) required for fast and effective equilibration.
These harsh conditions would denature most proteins and therefore Lehn et al
adopted a ‘pre-equilibrated’ DCC approach wherein the DCL is first generated in the
absence of any target. Upon equilibration, the library is frozen by raising the pH to
neutral conditions and then exposed to the protein target, in this case the enzyme
acetylcholine esterase (ACE), in a conventional enzyme assay.  Since the protein is
introduced only in a second discrete step separate from the DCL synthesis, a wide
range of reversible reactions can be used for generating a library with great diversity.
However, the adaptive processes that form the cornerstone of DCC are absent in this
protocol resulting in a static library of compounds. The second step of the process is
similar to the assaying of a conventional combinatorial library and as in these cases a
deconvolution strategy is required to identify hit molecules from the mixture.
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Figure 1.4 Hydrazides and aldehydes used in the acyl hydrazone DCL
Lehn and co-workers synthesized all possible acylhydrazones based on the 13
building blocks (Figure 1.4) and assayed their inhibitory activity towards
acetylcholine hydrolysis by ACE.  To establish a dynamic deconvolution approach
they then synthesized a preequilibrated DCL containing all members which was then
frozen and assayed. Sub-libraries, each containing all components except a hydrazide
or aldehyde building block, were prepared and assayed. Libraries missing either
hydrazide 7 or dialdehyde i, exhibited an increase in ACE activity thus identifying
the bis acyl hydrazone 7-i-7 as the best inhibitor of the enzyme with inhibitory
activity in the low nanomolar range.
A similar pre-equilibrated acyl hydrazone DCL method was then used by Lehn et al
to identify cationic inhibitors of Bacillus subtilis HPr kinase.12 The DCL design was
based on the scaffold structure 8, a previously discovered lead inhibitor (Figure 1.5).
A 440-membered DCL using 16 hydrazides containing nitrogen heterocycles, 2
monoaldehydes and 3 dialdehydes was generated under acid equilibration. Again,
25
based on a dynamic deconvolution strategy using 21 sub-libraries a bis-acyl
hydrazone 11 was clearly selected from the available compounds. A subsequent





























Bis-acyl hydrazone ACE inhibitor 11
IC50 = 18 M
Figure 1.5 Acyl hydrazone DCL components for kinase inhibition
Large DCLs using simple imine chemistry targeting the enzyme neuraminidase were
synthesized by Eliseev and co-workers.13 Neuraminidase is an important drug target







Figure 1.6 Anti-influenza drug Tamiflu
A diamine compound 13, structurally similar to tamiflu, was chosen as the scaffold
for DCL generation. Aldehydes chosen from a pool of 41 commercially available
compounds were added to the diamine 13 in the presence of sodium
cyanoborohydride. The initial imine DCC products are reduced in situ, and analysed
by HPLC as in the case of Lehn and Huc’s pioneering work. This library with just 20
aldehydes can theoretically generate 40000 library members counting the hemi-
aminals which have been previously seen by 1NMR of sample DCLs. A unique
feature of this DCL is its n x 1 stoichiometry:  the use of a single, divalent amine as
the scaffold which can, in principle, lead to the amplification of a single compound.
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Scheme 1.2 Imine DCL generated from diamine 13 and n aldehydes
A novel analytical method was adopted for the DCL. Given the large size of the
library, Eliseev reasoned that it would be too difficult to attempt a detailed
characterisation of all the compounds present at equilibrium. Instead, the DCL was
generated under conditions where the transient compounds were present in extremely
low concentrations and could not be detected by HPLC-MS in the absence of the
target.  However, in the presence of the enzyme, amplification of the best binders led
to detectable amounts of the compounds which could be characterised by HPLC-MS.
In this case compounds 18a, 18b and 18c were amplified with respect to the blank
composition (Figure 1.7). Control experiments using bovine serum albumin instead
of neuraminidase as the target protein produced no amplification which confirmed
that the DCL evolution was controlled by the neuramindase active site. Regenerating
the DCL in the presence of excess of zanamivir, a commercially available potent
neuraminidase inhibitor, also gave a library composition similar to the blank. The
absence of well-characterised blank libraries made it impossible to predict if the
amplification observed was the result of a genuine thermodynamic selection or
kinetic effects were involved. But given the precedence of imine chemistry used
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before in DCLs it would not be unreasonable to assume that a DCL effect was
operational in the system.
Biological assays of the re-synthesized hit compounds revealed that compounds 18a
and 18c have increased activity relative to scaffold 13. But, surprisingly amine 18b
which was amplified in the DCL is not a good binder exhibiting only a slightly
higher activity over the scaffold. Amine 18d on the other hand was not amplified at
all in the DCLs but is a reasonably better inhibitor. These false positive and negative
results are an inherent weakness of the imine DCL methodology and arise from the
separation of the molecular recognition events that control DCL evolution and
inhibitory activity assay. A subsequent report by Eliseev and co-workers extended
the study of their DCC system to ketones instead of aldehydes.14
Figure 1.7 Ki values for selected compounds from imine DCLs
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Beau has used DCC with a number of carbohydrate systems.15-18 Carbohydrate-
binding proteins are challenging targets since they often exhibit weak ligand
interactions with millimolar dissociation constants. An example is hen egg-white
lysozyme (HEWL), a glycosidase known to bind N-acetyl-D-glucosamine (D-
GlcNAc) with low millimolar affinity. Choosing the imine bond as the reversible
linkage to set up the DCL, the two D-GlcNAc and D-Glc compounds 22 and 23
along with equimolar amounts of six benzaldehydes (a-f) were equilibrated at pH 6.2
in the presence of sodium cyanoborohydride (Scheme 1.3). UV-HPLC analysis,
made possible by the 4-methylumbelliferyl chromophore appended beforehand to the
carbohydrate anomeric position, identified all the expected amines. The DCL
equilibrated in the presence of stoichiometric amounts of HEWL led to a small
amplification of two components, 22b and 22f (Figure 1.8). A control experiment
with chitotriose, a good HEWL inhibitor, did not show any amplification effects.
Biological assay confirmed that the amplified amine is about 100 times more active
than the starting D-GlcNAc scaffold.
Scheme 1.3 DCL of D-GlcNAc imines
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Figure 1.8 Amplification studies of Beau’s imine DCL targeting HWL. a) no HWL,
b) 1 equivalent of HWL, c) 3 equivalents of HWL, d) 1 equivalent of HWL and 3
equivalents of chitotriose. Adapted from reference 15.
Beau and co-workers then moved on to the more challenging glycosyltransferases
(GTs) as targets.16 The DCC approach is highly suitable in this case due to the
absence of GT crystal structures. But a drawback lies in the requirement of
stoichiometric amounts of the target protein necessary for measurable amplifications
since GTs are typically available in very small amounts. This issue prompted Beau to
formulate an interesting approach to imine DCLs.  Assuming that the reduced amines
share the binding characteristics of the parent imines and if a sub-stoichiometric
amount of protein is used, competitive binding of the amine products to the target
may decrease amplification over time. On the other hand if the amine products bound
significantly more weakly than the imine DCL members, there would be no
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competitive inhibition and constant amplification of the reduced amine products
would be observed. A carbohydrate-based imine DCL (Figure 1.9) envisaging this
scenario was designed targeting α-1,3- galactosyltransferase (α1,3GalT).
Figure 1.9 Library building blocks for imine DCL templated by α1,3GalT
The DCL had three types of components: Nucleoside aldehydes 25-29, diamine
linkers a–g, and D-galactose aldehyde 30. The GT target concentration at 1.6 μM
was significantly lower than the aldehyde and amine concentrations (82 and 542 μM
respectively). Double amination, where both the nucleoside and galactoside aldehyde
had condensed with a diamine, was not observed. The GT - templated DCL
amplified monoamine products 25e and 25f relative to 25a, 25b and 30f. No
amplification was observed in a control experiment with BSA, indicating molecular
recognition by the GT target as being responsible for amplification. Inhibition assays
established IC50 values of > 5mM for both amines (UDP-Gal IC50 = 73μM), with the
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amides 25’e and 25’f showing values of 1.1 and 0.4 mM, respectively (Figure 1.10)
which justifies the initial reasoning that Kamine << Kimine would be necessary for
amplification with the amides being ‘geometric’ mimics of the imine DCL
components.
Extending their work on galactosyltransferases to the β-1,4-galactosyltransferase
enzyme as a target for their carbohydrate DCL, Beau and co-workers observed only
modest amplifications for amines 25a and 25b. This result is not very surprising
since β-GT forms the glycosidic bond with inversion of configuration, whereas α-GT
does so with retention.
Figure 1.10 Assay data for DCL hit compounds
Congreve and co-workers introduced the concept of dynamic combinatorial X-ray
crystallography (DCX) as a method for fragment-based drug discovery.19,20 The
technique has unique advantages over standard DCC approaches since along with
direct identification of the ligand, the electron-density maps aid in understanding the
detailed binding mode of the hit compound.  The authors studied a kinase enzyme
cyclin-dependant kinase 2 (CDK2) as the target with a DCL based on the aryl
hydrazine A and isatin B scaffolds (Scheme 1.4). The library members were selected
so as to present a range of functionality to the lipophilic pockets in the ATP binding
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site of the protein. The suitability of hydrazone chemistry for the DCL experiment
was established by reacting each of the 30 pairs of reactants in 20% aqueous DMSO
over a period of 48 hours. After ensuring that all the expected hydrazones were being
formed, the reactions were performed in the presence of CDK2 crystals first as
individual pairs of hydrazine and isatin reactants, and then as mixtures. Analysing
the electron density maps revealed a potent binder with inhibitory activity at 30 nM.
Scheme 1.4 Hydrazone formation for dynamic combinatorial X-ray crystallography
Although the DCX technique seems to be very powerful in ligand discovery
applications, doubts remain as to whether a real DCC effect operates in the system
since only a small amount of protein is used in the soaking experiments compared to
the amount of library components in solution.  The moot question is whether the
protein structure influences the hydrazone equilibrium within the confines of the
crystal or if a template effect operates under kinetic control.
1.3.2 Disulfide bond formation
Disulfide bonds are ubiquitous in biology and play an important role in the folding of
proteins and maintaining the redox states of cells.21 The reversible nature of this
bond has been known for some time and therefore it did not take very long for
researchers to adapt it for DCC applications. The question whether a mixture of
equilibrating disulfides can evolve and respond to template effects was answered for
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the first time by Hioki and Still in 1998.22 Their experiments used a DCL based on
the disulfide exchange to identify a small molecule receptor for the tripeptide
(D)Pro(L)Val(D)Val. After this initial report extensive work undertaken by the Lehn
and Sanders groups in the late 1990s established the reaction as a powerful tool for
DCC. 23,24
Disulfide exchange proceeds readily in water under near neutral conditions (pH 7-9)
which makes it suitable for use with biomolecular templates. The reaction can be
operated in the presence of oxygen or catalytic amounts of thiol and a mild base. The
exchange process is switched off by acidification which aids library analysis. These
bonds are sufficiently stable under aqueous conditions and exhibit reasonable
chemoselectivity tolerating a number of functional groups. The exchange process can
be used with protein templates provided no thiols or disulfide groups are present on
the surface of the protein. Any such groups embedded in the interior of proteins
would not generally pose a problem since it would be difficult for small molecule
thiols at low concentrations to access these groups.
Lehn and Ramström reported the first example of disulfide bond formation in a
carbohydrate- based DCL targeting a protein.23 Concanavalin A (Con A) is a well
characterised carbohydrate- binding protein with high specificity for the branched
trimannoside unit (Man)3 42. A DCL was designed based on an assumption that the
two peripheral mannoside units in (Man)3  are responsible for binding interactions
with the lectin while the central unit serves as a linker. Accordingly mannoside-
based building blocks with a phenylamido chromophore and short chain alkyl thiols
were synthesized. The thiols formed disulfides under appropriate conditions with the
disulfide bonds functioning as reversible linkers between the two carbohydrate-based
head groups. Since most non-aromatic disulfides have similar reactivity their
equilibrium constants are close to unity. This feature ensured an iso-energetic DCL
with all product structures expressed to a similar extent at equilibrium.
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Scheme 1.5 Disulfide exchange DCL templated by ConA
The DCL based on the four disulfides 43a, 43d, 43e and 43f was equilibrated at pH
7.4 for 2 weeks with dithiothreitol (DTT) as an initiating agent and then analysed by
HPLC (Figure 1.11). All the ten expected ditopic carbohydrate combinations could
be identified. The Con A target immobilised on sepharose beads was then introduced
into the DCL and equilibrated making it the first example of a solid-supported
protein used in DCC. Product amplification was identified first by quantifying
components that had been removed from the solution phase and then by quenching
the DCL with acid and washing off bound components from the resin beads. There
was a clear preference for the D-mannose homodimer followed by the D-mannose
heterodimers. A slightly higher yield for the selected structures was observed if the
receptor was present in the mixture from the beginning of the scrambling process as
compared to it being added after pre-equilibration. HPLC resolution problems were
encountered for larger libraries but even in such cases quenching and elution from
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the beads clearly showed the expected mannose dimers bound to the immobilized
protein.
Figure 1.11 LC analysis of disulfide DCLs. Trace a): Starting disulfides 43a, d, e, f.
Trace b): Equilibrated DCL (no target). Trace c): Equilibrated DCL in the presence
of ConA. Trace d)Eluate of bound species from immobilised ConA. Reproduced from
reference 23.
Although the amplification effects in this study were relatively weak as expected for
a low affinity system it clearly demonstrated the utility of mild disulfide exchange
for DCC applications with protein targets. A similar DCL based on acyl hydrazone
exchange targeting the same Con A binding site was subsequently reported by
Lehn.25 In this case due to the acidic conditions required by the exchange reaction a
pre-equilibration / deconvolution approach was adopted.
The concept of disulfide-based DCLs targeting proteins was extended by Hunter and
Waltho to the identification of bifunctional ligands for calmodulin (CaM).26 This
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protein target plays a major role in regulating a range of physiological processes by
binding to enzymes. It has a unique structure with two independently mobile
domains connected by a flexible linker. Therefore, the design of the DCL targeting
CaM was based on a scaffold consisting of two hydrophobic peptides joined together
by a flexible linker. The library components consisting of cystine dimers of
























































Figure 1.12 Cystine dimer components for Calmodulin DCL and LC analysis of
cystine DCL. Trace A shows the DCL templated with CaM while trace B shows the
blank DCL. Dipeptides ce and cc are amplified (Reference 26)
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The DCL upon equilibration for 48 hours under standard disulfide exchange
conditions at pH 7.5 expressed all the 15 expected disulfide exchange products as
analysed by LC-MS (Figure 1.12). The library equilibrated in the presence of CaM
was subjected to a centrifugation / filtration step to separate the protein / bound
components from the mixture. Unfortunately the filtration membrane affected the
library composition and HPLC analysis of the filtrate did not yield any meaningful
results. However, analysing the bound components by denaturing the protein and
comparing with the blank library composition indicated significant amplification for
the dimer ce (80%) and a smaller amplification for the dimer cc (10%). A binding
assay performed for these bifunctional ligands established Kd values of 10 and 210
μM respectively. These affinities were two orders of magnitude greater than the
corresponding monofunctional ligands. This elegant study proved the use of disulfide
chemistry in DCLs targeting more complex proteins.
Danieli and co-workers adopted a similar approach to design a DCL of bivalent
ligands linked by flexible disulfide linkers targeting the tubulins.27 The antitumour
agents thiocolchicine and podophyllotoxin were chosen as the scaffolds for the
library. These compounds were appropriately derivatised to form homo and hetero-
dimers through disulfide linkers (Figure 1.13). An in situ templation with the
intended target microtubulin did not work due to the poor aqueous solubility of the
DCL members. The tubulin itself collapsed in organic solvents which ruled out its
use in an acetone –based DCL.  Albumin and subtilisin, two organic solvent tolerant
proteins used as alternative targets, influenced the amounts of the homodimers 45
and 48 and the hetero-dimer 51 in a DCL generated in acetone and triethylamine
(TEA).
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Figure 1.13 Disulfide DCL based on thiocolchicine and podophyllotoxin
Abell and Ciulli have recently combined ideas in fragment based drug discovery with
DCC to probe adenosine binding sites on the enzyme Mycobacterium tuberculosis
pantothenate synthetase.28 They used 5’-deoxy-5’-thioadenosine (55) as an anchor
building block which can undergo thiol-disulfide exchange templated by the enzyme.
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Library analysis by HPLC led to the identification of a benzyl disulfide derivative
(56) which was susequently derivatised to generate novel compounds that bind














Figure 1.14 Anchor building block (55) targeting the pantoate site and the amplified
benzyl disulfide derivative(56)
Erlanson et al working at Sunesis Pharmaceuticals tried to harness the power of
disulfide exchange chemistry in a conceptually new fragment-based drug discovery
method termed tethering.29-35 This approach has many features common with
established DCC protocols and is illustrated in Figure 1.15. It uses a cysteine residue
on the target protein surface which undergoes reversible disulfide exchange to select
small molecule thiol fragments from solution.  These weak-binding thiol fragments
can then be elaborated to develop drug candidates with better affinity for the target
protein. A limitation of this methodology is the requirement of a cysteine residue
close to the active site of interest. If the protein does not have the required cysteine
residue at a suitable location then they have to be introduced using site-directed
mutagenesis. Though this is a well established procedure in protein chemistry it still
requires structural information about the protein to exactly pinpoint the location for
the thiol to be introduced on the protein surface.
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Figure 1.15 The concept of tethering
The first successful demonstration of this approach used the enzyme thymidylate
synthase (TS) as the target.35 This protein is a well characterised anti-cancer drug
target with an active site cysteine. The small molecule library was designed around
the general scaffold structure (Figure 1.15). It contains a variable fragment part
derived from a carboxylic acid that could be connected to a terminal amine through a
disulfide linker. The role of the terminal amine is primarily to increase solubility of
the components in aqueous solution. Library sizes were in the range of 8-15
disulfides with individual concentrations at 0.2 mM. The disulfide bonds were
exchanged under standard conditions in the presence of 15 μM protein followed by
LC-MS analysis where the hit compounds covalently bound to the proteins were
identified. The MS analysis assumed that the ionisation profile of each tethered
protein-complex is similar with each tethering experiment featuring fragments of
distinct molecular mass differing by at least 10 Da.
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Figure 1.16 MS data of tethered complexes. Data A shows a tethering experiment
between TS and 10 disulfides equilibrated for 1 hour. Data B illustrates tethering
with varying concentrations of 2-mercaptoethanol. Data C shows tethering with
varying pool size of disulfides. Reproduced from reference 35.
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Figure 1.16 shows the results of these tethering experiments. For experiments with
no hits the deconvoluted MS shows peaks for the unmodified protein (U) along with
TS tethered to 2-aminoethanethiol (L) which is common to all the library
components. A clear hit was observed with an N-tosyl-D-proline fragment (Figure
1.16A). Thermodynamic control over the selection was proved by varying the
amount of catalytic thiol for disulfide equilibration (Figure 1.16B). An advantage of
the tethering technique is its scalability with the N-tosyl-D-proline fragment chosen
from experiments containing over 100 compounds (Figure 1.16C). The study was
extended to a library of 1200 compounds based on the proline fragment P thus
producing a SAR picture which was supplemented with crystal structures of the
protein with the fragment bound at the active site. Significantly the conformation of
fragment P in the tethered complex was very similar to a non-covalent complex
between N-tosyl-D-proline and TS which shows that the covalent linkage in the
tethering experiment does not affect the binding mode of the fragment. Inhibitors of
vastly improved affinity were then developed by linking up the side chain of the TS
cofactor methylenetetrahydrofolate. Based on this initial success the tethering
concept has since then been applied to a number of targets.30-34
1.3.3 Hemithioacetal formation
Recently Ramström et al have reported the use of hemithioacetal formation for DCC
applications.36 Addition of thiols to aldehydes and ketones leads to the reversible
formation of hemithioacetal stereoisomers but the equilibrium lies towards the
starting components. This results in virtual dynamic systems with only transient
amounts of the hemithioacetals detected in solution. The library used by the authors
consisted of five thiols and two aldehydes generating 10 transient hemithioacetals
(20 stereoisomers) in aqueous conditions (pH 7.2, ambient temperature) suitable for a
protein (Scheme 1.7). The target protein, β-galactosidase, was chosen on the basis of
the absence of cysteine residues at the active site which would prevent any
competing hemithioacetal formation with the free aldehyde library components. The
protein is a well-characterised hydrolase catalysing the hydrolysis of glycosidic
linkages of β-galactosides into the corresponding galactoses and alcohols.
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Under the conditions of library generation (pH 7.2, ambient temperature) in the
absence of the enzyme no characteristic NMR signals were seen for hemithioacetals
but upon reducing the pH from 7.2 to 4 specific hemithioacetal signals were
observed slightly downfield from the hydrate signals of the corresponding aldehydes.
For the enzyme-templated virtual DCLs Ramstrom and co-workers used saturation
transfer difference (STD) NMR spectroscopy to identify bound ligands. In this
technique magnetization is transferred from protein active site protons to those of the
bound ligand which is detected upon ligand dissociation provided the relaxation time
scale is slower than the rate of dissociation.  Hemithioacetals 57-A and 57-B were

















































































































Scheme 1.7 Virtual dynamic hemithioacetal system targeting β-galactosidase
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1.3.4 Enzymatic methods
An early example of DCC using enzyme-catalysed reactions was reported by Venton
et al in 1997. 37 Catalysing reversible reactions using enzymes is a practically sound
idea since they work under physiological conditions and can be applied to a range of
C-C and C-X bond forming reactions. Venton chose the protease-catalysed amide
bond synthesis / hydrolysis for generating his DCL. For the protease-based DCL two
small peptides YGG and FL were used as the starting points. Incubating these with
the broad spectrum protease thermolysin yielded over 15 short peptide sequences. In
another experiment incubating the dipeptides VA and AL with thermolysin followed
by cathepsin C produced 7 out of the possible 9 dipeptides. These results proved that
the protease scrambles the amino acid sequence of the starting peptides. To test the
protease DCL with a suitable receptor, a mixture of BSA hydrolysates and the
tripeptide GPR was incubated with thermolysin and fibrinogen separated by a
dialysis membrane. Fibrinogen is a readily available protein involved in the blood
clotting process while the tripeptide GPR is a known binding motif for the fibrinogen
target. Analysing the composition of the templated mixture and comparing it with
control experiments identified amplification of the peptides GPRL, GPRF and
DKPDNF by fibrinogen. The peptides assayed for binding with fibrinogen gave Ka
values in the range of 10-4 M-1, an affinity two-fold lower than the tripeptide GPR.
This study by Venton is impressive for its use of enzyme- catalysed amide exchange
in a selection process. However reversible amide bond formation using chemical
methods in a DCC context is still an open challenge though some progress has been
reported recently by Stahl.38-40
A second example of an enzyme-catalysed reversible reaction used to generate a
DCL was reported by Flitsch and Turner (Scheme 1.8).41,42 The library was based on
an aldolase enzyme-catalysed breaking up of sialic acid 64a to N-
acetylmannosamine 62a and sodium pyruvate 63. A small DCL consisting of N-
acetylmannosamine 62a, D-mannose and D-lyxose was set up in the presence of N-
acetylneuraminic acid (NANA) aldolase. Equilibration of the aldol products took 16
hours while control experiments proved the system to be under thermodynamic
control.   Wheat germ agglutinin (WGA), a plant lectin and a known weak binder of
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sialic acid was selected as the target of the DCL. A clear amplification was observed
for the natural substrate sialic acid 64a at the cost of the adduct 64b. Thermodynamic
measurements established the binding affinity of 64a to WGA as 172 M-1. No
binding could be detected for compound 64b.
Scheme 1.8  Aldol reaction catalysed by N-acetylneuraminic acid(NANA) aldolase to
produce sialic acid
1.3.5 Pseudodynamic combinatorial chemistry
Pseudodynamic combinatorial chemistry is a very elegant strategy introduced by
Gleason and Kazlauskas in 2002.43,44 They combined an irreversible synthesis of the
library members with an irreversible destruction step. The best binding compounds
form a complex with the target protein and survive the destruction. Scheme 1.9
illustrates the idea for a peptide-based pseudoDCL targeting carbonic anhydrase
(CA). The reaction system is compartmentalised in a three-chambered reaction
vessel; the first chamber functioning as the synthesis chamber, the second containing
the target enzyme and thus functioning as the screening chamber, and the third
functioning as the destruction chamber in which the weak binders are destroyed.
Practically this is achieved by using dialysis bags suspended in a solution. Diffusion
of components across the three chambers imparts a ‘pseudodynamic’ nature to the
whole system while the irreversible synthesis and destruction steps vastly improve
the selectivity of the process.
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Scheme 1.9 The pseudoDCL experiment
Dipeptide binders are created in the synthesis chamber through an addition of amino
acids 65 to the immobilised ester 66. These dipeptides (67) diffuse into the screening
chamber and establish a binding equilibrium with the target CA. The free dipeptides
which do not form a complex with the CA diffuse into the third destruction chamber
where they are hydrolysed back to the amino acids using excess of a broad spectrum
protease, pronase. This excess was used to ensure that the natural selectivity of the
protease would not create large differences in the rates of the synthesis and
destruction steps. The amino acid building blocks then migrate to the first synthesis
chamber and are reused in the synthesis step. The stock of the ester 66 was
constantly replenished. The higher affinity members which are protected from
destruction are amplified at the expense of the poor binding molecules.
The designed pseudo-DCL used two amino acid building blocks along with four
immobilised esters.  After seven cycles of replenishing the esters (112 hours) the best
binding dipeptide was amplified by a factor of 100 over the next best binder even
though the ratio of their binding constants is only 2.3:1. This increased selectivity of
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the pseudodynamic approach in comparison to classical DCLs may be due to the
iterative nature of the process.
1.3.6 Michael addition of thiols to enones
Recent work by Greaney and co-workers has led to the introduction of the conjugate
addition of thiols to Michael acceptors as a new strategy for generating adaptive
DCLs (Scheme 1.10).45,46 The reaction takes place in water under mildly basic
conditions at room temperature which permits its use with biological templates. This
exchange process is reasonably fast at physiological conditions and extremely slow
and irreversible at low pH, allowing the reaction to be controlled by a simple change
in pH.
Scheme 1.10 Reversible Michael addition of thiols to enones
The enzyme glutathione-S-transferase (GST) from the helminth worm Schistosoma
japonicum was selected as the target for the conjugate addition DCC experiments.
These enzymes catalyse the conjugation of glutathione (GSH, 69) to a wide range of
electrophilic substrates thereby aiding cell detoxification and are therefore
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A Michael acceptor, ethacrynic acid (EA, 73), GSH (69) and three tripeptide
analogues (70-72) were used to generate a preliminary DCL probing the GSH
binding site of SjGST. Ethacrynic acid 73 is a known inhibitor of the GST class of
enzymes and binds at the hydrophobic region of the active site. The four expected
Michael adducts 74-77 equilibrated in an hour and were identified by LC-MS. Upon
addition of an equivalent of enzyme, the native substrate GS-EA (74) was amplified
to 92% of total adducts concentration compared to 32% in the absence of the protein.
Binding assays performed on the compounds showed a difference of an order of
magnitude between the selected compound 74 (IC50 = 0.32 µM) and compound 77
(88 µM)
A larger library consisting of a single thiol, GSH, and 14 EA analogues was then set
up to probe the hydrophobic binding site of the same protein (Scheme 1.12). This
region of the active site is not conserved across the different GST isoforms and
therefore would be crucial in the development of isoform-specific inhibitors. The
templated library was found to amplify three compounds 78a, 78m and 78n chiefly
at the expense of the lysine derivative of EA 78f. Binding assays established that the
selected compounds were more potent binders (IC50 = 0.61 µM for 78a) than the
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Scheme 1.12 Thiol conjugate addition DCL templated by SjGST (Reference 46)
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1.4 Dynamic Combinatorial Resolution
Ramström introduced the concept of dynamic combinatorial resolution as a novel
method for the kinetic screening of dynamic libraries.47-49 The approach tries to
resolve some of the difficulties associated with classical DCC: the analysis of
complex mixtures and the requirement of stoichiometric amounts of the target
molecule. A complete resolution of dynamic libraries in a one-pot process can be
achieved using catalytic amounts of the target if the DCL and the binding event can
be coupled to a second kinetically controlled step mediated by the target enzyme.
This irreversible step may result in a stable product which is easy to isolate and
identify.
1.4.1 Transthiolesterification DCR
Initial work by Ramström and coworkers demonstrated the use of
transthiolesterification for the generation of DCLs in neutral aqueous solutions,
conditions highly desirable for biological targets.47 These DCls were then subjected
to a DCR process using hydrolases as targets. The target hydrolase of choice,
acetylcholinesterase, is a serine hydrolase which plays a very important biological
role in the hydrolysis of the neurotransmitter acetylcholine (80) to acetate and
choline (81) (Scheme 1.13). The enzyme is highly efficient with hydrolysis rates
approaching diffusion-controlled limits around 109 M-1s-1, a factor important in the
design of a proof-of-concept DCR.
Scheme 1.13  ACE catalyses the hydrolysis of acetylcholine
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The dynamics of the transthiolesterification depends on the structure of the thiols.
Under neutral pH conditions the exchange rate was directly correlated to the pKas of
the thiols; those with pKa less than 8.5 equilibrated rapidly. Thiolesters based on
secondary thiols were considerably less stable than acetylcholine and the equilibrium
favoured the reactants in the case of aromatic thiols. The rate of the exchange
reaction can be increased by increasing the pH of the solution but this would also
increase the rate of unwanted hydrolysis. The DCR concept using
transthiolesterification is shown in Scheme 1.14.
Scheme 1.14  Transthiolesterification DCR
A 25-compound isoenergetic DCL was generated from a series of thiolesters and
thiols followed by the addition of catalytic amounts of acetylcholinesterase. The
protein immediately recognised the best substrates which were hydrolysed resulting
in a loss of the acyl component from the library. The free thiol generated was
accommodated in the dynamic library leading to an increase in the population of the
hydrolysed species. The enzyme showed a clear preference for the acetyl and the
propionyl groups with the acetyl species hydrolysed faster than the propionyl
compound. After substantial hydrolysis of these two substrates the butyrate ester was
hydrolysed at a smaller rate while the rest of the acyl groups remained untouched. A
series of hydrolases tested with the library showed some activity depending on the
respective enzyme specificities. Control experiments with bovine serum albumin
(BSA) did not show any activity.
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Scheme 1.15 DCl for screening hydrolase substrates
1.4.2 Cyanohydrin DCR
The DCR concept was extended by Ramstom et al to the screening of lipase
substrates using cyanohydrin formation for the generation of the DCL (Scheme
1.16).48 The reaction is an example of reversible C-C bond formation with the
product cyanohydrins amenable to further functional group transformations. The
lipase target enzymes are esterases which recognize a broad range of unnatural
substrates to catalyse esterification reactions. The chief biological role of these
proteins is to catalyse the hydrolysis of triglycerides into fatty acids and glycerol at
water –oil interfaces.
A unique method using acetone cyanohydrin adducts was used to generate
cyanohydrin DCLs under mild conditions. Treating the acetone cyanohydrin with
triethylamine base in chloroform releases the cyanide ion along with free acetone in
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organic solvents. The released cyanide ions react with aldehydes or ketones to
generate a dynamic library of stable cyanohydrin adducts.
Scheme 1.16  Cyanohydrin DCR
The authors used a small library of five different benzaldehydes along with acetone
cyanohydrin and triethylamine which attained equilibrium in 3 hours as monitored by
1H-NMR (Scheme 1.17). Interfacing the library with lipase and isopropenyl acetate
104 as an acyl donor selected the cyanoacetate product 105 as the major product of
the reaction.
Scheme 1.17 Cyanohydrin DCLs targeting lipases
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1.4.3 Nitroaldol DCR
The nitroaldol reaction, also known as the Henry reaction, was introduced to the field
of DCR, again by Ramstrom and co-workers (Scheme 1.18).49 It involves the
nucleophilic addition of a nitroalkane to a carbonyl group forming a C-C bond. The
reaction is thermodynamically controlled and can be accelerated in the presence of
organic or inorganic bases or quaternary ammonium salts.
Scheme 1.18 Nitroaldol DCR
A ten-membered β-nitroalcohol DCl including all possible enantiomers was
generated at 40oC from equimolar amounts of five aromatic aldehydes and 2-
nitropropane 108 (Scheme 1.19). 10 equivalents of triethylamine base were used to
catalyse the library generation and equilibrium was established in 18 hours. Higher
temperatures affected the enantioselectivity of the enzymatic reaction and also
decomposed the library members.
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Scheme 1.19 Nitroaldol DCLs targeting lipases
Selection of the lipase target required careful screening of a series of enzymes and
acyl donors since lipase-catalysed transesterification of β-nitroalcohols had not been
reported earlier in literature. The selected lipase Pseudomonas cepacia and five
equivalents of the acyl donor, p-chlorophenyl acetate, were added to the nitroaldol
library. Two of the β-nitroalcohols 109 and 113 were selectively transesterified to the
corresponding acylated products.  The overall yield for the two products was 24% in
24 hours and the reaction went to completion (95%) after 20 days. The DCR process
was highly enantioselective with the R-enantiomer of the ester 115 resolved to 99%
ee and the R-enantiomer of 116 to 98% ee. These examples established the
conceptual framework of DCR as a valuable tool for the screening of a DCL of
potential substrates using less than equimolar amounts of the target enzyme.
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1.5 Target accelerated synthesis
Product distributions of reactions under kinetic control reflect the relative differences
between the initial and transition state Gibbs energies and therefore biasing such
kinetic processes would involve changing the energies of the transition states. This is
generally achieved by preferential binding and stabilization of a selected transition
state by an added template which would result in an increased rate of formation of
the selected product. This method which leads to selection of the best binding
molecule using irreversible reactions under kinetic control is referred to as target-
accelerated synthesis (TAS) and is complementary to the thermodynamic approach
(Figure 1.17).50
Figure 1.17 Target-accelerated synthesis
An elegant example was provided by Nguyen and Huc who used the active site of
bovine carbonic anhydrase (BCA II) to template the formation of aromatic
sulphonamide-based inhibitors through an irreversible nucleophilic substitution
reaction (Scheme 1.20).51 Products with a nine-fold difference in binding constants
exhibited a two-fold increase in rate. Control experiments with bovine serum
albumin (BSA), a protein that had no affinity for the building blocks, proved
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conclusively that BCA II actually accelerates the formation of the best binding
species.
Scheme 1.20 Alkylation of thiols used to identify best binding ligands for BCA II
The most successful target-accelerated synthesis method was developed by Sharpless
who used the Huisgen 1,3-dipolar cycloaddition of alkynes and azides to form 1,4-
disubsituted-1,2,3-triazoles as an ‘ in situ click’ reaction.52-54 The reaction has many
unique advantages for use in the presence of biological templates. The azide and
alkyne functionalities are generally compatible with biomolecules and aqueous
conditions while the triazole in the product is in many ways similar to the amide
bond. The applicability of this reaction has been demonstrated for important target
enzymes like carbonic anhydrase II and acetylcholinesterase (Scheme 1.21).53,54
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Scheme 1.21 In situ click chemistry targeting acetylcholinesterase
For a successful target-accelerated synthesis experiment the target should
simultaneously bind both the starting materials and also significantly accelerate the
irreversible coupling reaction.50 The approach would most likely fail in cases where
two weakly binding species are linked together to form a strong binder. Optimising
substituents around a tight- binding anchor scaffold would work only if the
substituents themselves are relatively good binders. Such kinetic systems offer better
selectivity than thermodynamic methods but are more difficult to control.
1.6 Conclusions and aims of this project
Protein-directed DCC is an emerging field which combines library synthesis and
screening into a single step. The scope of the field depends heavily on the range of
reversible synthetic chemistry that can be used under biocompatible conditions. C=N
bond forming reactions were the first to be used to demonstrate the concept but lack
true adaptability. Reversible disulfide formation, Michael addition of thiols to enones
and enzymatic methods have attempted to provide alternatives to imine chemistry in
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biological DCC. Pseudodynamic and DCR methods have been developed to
overcome the requirement of stoichiometric amounts of protein targets, a constraint
inherent to the DCC concept. As this field evolves new ways of generating
biocompatible dynamic libraries are needed in order to expand the structural
diversity accessible to DCC.
This aim of this project is to develop new methods for adaptive DCLs which can be
readily interfaced with protein targets. Our experiments establish catalysed acyl
hydrazone formation as a new strategy for generating DCLs targeting proteins.
Chapter II of this thesis deals with the development of this methodology and its
application for the identification of isoform-specific binders for two different GST
enzymes. Chapter III outlines our efforts towards developing multi-level DCLs
which use two orthogonal reversible reactions as an entry point into the field of
systems chemistry.
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A critical review of literature indicates that the field of dynamic combinatorial
chemistry has the potential to develop into an extremely useful tool for exploring
protein-ligand interactions even in the absence of extensive structural information on
the protein binding site. The main challenges in implementing DCC with biological
templates lie in performing the synthetic chemistry under conditions which maintain
the structural and functional integrity of the biomolecule. The reversible reactions
must take place under mild physiological conditions, eliminating those that are
incompatible with water. The process should not interfere with either functional
groups present on the bio-template or the molecular recognition involved in the
selection process. The exchange process should attain equilibrium within a
reasonable timeframe in which the structural and functional integrity of the template
is preserved. Since very few reversible reactions meet these strict requirements of
biocompatibility, Lehn proposed two limiting protocols for constructing DCLs
targeting biomolecules: adaptive and pre-equilibrated.1 The adaptive DCL involves a
bio-compatible reversible reaction so that library generation and selection of the best
binders can be performed in a single step in the presence of the target. The DCL may
be real or virtual but the binding events involving the target control the evolution of
the library composition. The adaptive approach usually requires stoichiometric
amounts of the target for appreciable amplification to be observed.
In the case of pre-equilibrated DCLs the reversible reaction is not compatible with
the biomolecular template. Therefore the dynamic library is generated in the absence
of the target which is introduced into the system only after the exchange process has
been switched off. This compromises the adaptive feature of DCC and is akin to the
post-synthesis screening of a static combinatorial library. An advantage of this
method is that the screening process in the second step does not require
stoichiometric amounts of the target. This is important only when small quantities of
target protein are available or if it is very expensive.
Methods for generating truly adaptive DCLs targeting proteins are limited and are
mostly based on the disulfide exchange2 or thiol conjugate addition3,4 which have
been reviewed in Chapter I of this thesis. This lack of reaction diversity is a major
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constraint, limiting the use of this powerful concept for drug discovery applications.
The success of the DCC approach to studying biological systems, therefore, depends
on the development of new tools for generating adaptive biocompatible DCLs. This
chapter deals with our attempts towards the development of new methods for
adaptive DCLs which can be readily interfaced with protein targets. We have
identified nucleophilic catalysis of acylhydrazone equilibration using aniline as a
promising approach to generate truly adaptive DCLs under near-physiological
conditions.
2.2 The reaction of choice: Acylhydrazone exchange
Reversible amine/carbonyl condensations generating imines, hydrazones and oximes
are ideal candidates for biological DCC applications given the prevalence of imine
chemistry in biochemical systems.5 Simple imines form rapidly but present serious
analytical and isolation problems due to their inherent instability in aqueous solutions
(Scheme 2.1A). With hydroxylamines and acyl hydrazides the equilibrium lies
towards the products with relatively stable oximes and hydrazones being formed but
the kinetics is much slower especially under physiological conditions.6 The reactions





































Scheme 2.1 Transimination reactions for DCC. A: Imine DCLs- reversible addition
of amines to aldehydes gives unstable imines that cannot be isolated or analysed
directly, necessitating an in situ reduction step. The resultant static library of amines
may or may not share the binding profile of the imine precursors. B: Acyl hydrazone
DCLs- reaction of aldehydes with hydrazides gives acylhydrazones that have good
stability and are amenable to analysis. Equilibration requires acidic conditions that
are incompatible with a biological target.
The greater intrinsic hydrolytic stability of hydrazones and oximes over imines is
believed to be due to electron delocalisation (Scheme 2.2). Resonance forms IV and
VI contribute towards increasing the negative charge density on the imine carbon
thereby reducing its electrophilicity.9
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Scheme 2.2 Hydrolytic stability of hydrazones and oximes
Acylhydrazone exchange was introduced to DCC by the Sanders group who applied
it to a large number of abiotic DCC systems.10-12 However this reaction has not found
much use for adaptive biological DCC due to the acidic conditions required for
equilibration in a reasonable timeframe. An exception is the work by Poulsen  who
has shown that slow equilibration of acylhydrazones, taking one week at pH 7.2, can
enable the identification of binders for the enzyme carbonic anhydrase using mass
spectrometry.13 The acylhydrazone functionality has unique features; the amide bond
provides hydrogen bonding sites important for protein templates while the imino
bond is responsible for the dynamic character through reversibility (Figure 2.1).14
We envisaged the use of this reaction for generating adaptive DCC systems with
protein templates if a suitable catalyst could be found to accelerate the exchange








Figure 2.1 The Acylhydrazone linkage
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Classic work from Jencks in the 1960s led to the identification of aniline derivatives
as nucleophilic catalysts for semicarbazone formation15 which was recently extended
to hydrazone and oxime formation in peptide ligation systems by Dawson (Scheme
2.3A).16-18 Aniline-catalysed transimination proceeds through aniline Schiff base
intermediates which are highly unstable in aqueous conditions (Scheme 2.3B).16
This allows for large concentrations of the catalyst to be used, facilitating fast
equilibration of hydrazones and oximes even in millimolar concentrations.
Consistent with nucleophilic catalysis, aniline does not affect the overall equilibrium
constant of the reaction and thus maintains equilibrium distribution of reactants and
products. In this project we explore the use of aniline to generate acylhydrazone
DCLs under conditions favourable for proteins.
A
B
Scheme 2.3 Aniline catalysis of acyl hydrazone formation and exchange. A: Aniline
catalysis used by Dawson for peptide ligation systems. B: A highly electrophilic
transient aniline Schiff base accelerates acylhydrazone exchange
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2.3 The target protein: Glutathione S-tranferases
The Glutathione Transferases (EC 2.5.1.18, GSTs) are detoxification enzymes which
catalyse the conjugation of glutathione (GSH) 69, to a wide variety of hydrophobic
electrophilic substrates (Scheme 2.4).19,20
Scheme 2.4 Reactions catalysed by the GSTs
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Based on their substrate specificity and primary structure cytosloic GSTs are divided
into five different classes (alpha, mu, pi, sigma and theta).21,22 The enzymes exist as
homo- or heterodimers with each monomer having its own active site consisting of a
GSH-binding site (G-site) and a hydrophobic binding site (H-site) (Figure 2.2).23 The
G-site is conserved across different isoforms but the H-site is highly diverse and
responsible for the large variety of substrates recognized by the GSTs. The catalytic
role of the GSTs is dependent on highly conserved tyrosine, serine or cysteine
residues at the G-site.24 Upon binding to the enzyme, the pKa of GSH drops from ~
9.5 to ~ 6.8 units which aids deprotonation to form the more nucleophilic thiolate
anion under physiological conditions.  In addition to these two sites some GSTs have
a third ligandin-binding site (L-site) which is able to bind large hydrophobic
molecules like steroids, bile salts, fatty acids or drugs.25 The exact location of this L-
site is uncertain.
Figure 2.2 Structure of GST that illustrates the H- and the G- sites. (Grey: monomer
1; yellow: monomer 2; green: G site; red: H site)
These well-characterised proteins are relatively stable and easy to purify. They can
be easily assayed using the ‘CDNB assay’ which uses the aromatic nucleophilic
substitution reaction between GSH and 1-chloro-2,4-dinitrobenzene (CDNB, 135)
considered to be a universal GST substrate (Scheme 2.5).19
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Scheme 2.5 The CDNB assay for GSTs
The GSTs are considered to be important drug targets in cancer since resistance to
chemotherapeutic drugs has been directly correlated with overexpression of GSTs in
tumour cells.26 Previous work in the Greaney group involved the development of
thiol conjugate addition DCLs for identifying GST inhibitors.4 The bisubstrate
architecture of these proteins makes them targets eminently suitable for a fragment-
based DCC approach since the concept relies on reversibly connecting two sets of
fragments together to generate a dynamic library.1 In this project, we have focussed
on two recombinant GST isozymes as targets, SjGST from the helminth worm
Schistosoma japonicum, a drug target in tropical disease,27 and hGST P1-1, a human
isoform important in cancer.26
2.4 Results and discussion
2.4.1 Design of the dynamic acylhydrazone library
A critical parameter in the design of a DCL targeting proteins is the selection of the
building blocks which undergo reversible exchange. At least some of the building
blocks should have characteristic molecular features that can be recognised by and
interact with the target binding site. We envisaged an n x 1 DCL system which uses a
biologically active scaffold that can be derivatized at a single position with n
components. In comparison to n x n DCLs the combinatorial aspect is diminished in
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the n x 1 case generating only n + 1 components in the library. However
amplification in this case can be very strong and, in principle, the entire library can
be amplified to a single member. The combinatorial size of the library can be
improved by using multivalent scaffolds in the n + 1 DCLs without sacrificing the
amplification.
Our design of the DCC experiments involved using a scaffold aldehyde 137
structurally related to the known GST substrate, chlorodinitrobenzene (CDNB) 135.
We expected this structure to have some affinity for the enzyme H-site. Upon
incubating this aldehyde 137 with 1 equivalent of GSH and catalytic amounts of
SjGST in ammonium acetate buffer (50 mM, pH 7.2) we identified the glutathione
conjugate aldehyde 138 formed by LC-MS (Scheme 2.6). Interestingly, aldehyde
139, a regioisomer of 137, also gave glutathione conjugates with the enzyme
(Scheme 2.7). Control experiments under similar conditions in the absence of GST
did not produce any glutathione conjugates for both the aldehydes indicating that
they act as substrates for the protein and access the H-sites. Experiments repeated
with the human isoform hGSTP1-1, gave very similar results. (Both enzyme samples




























































Scheme 2.7 The GSTs catalyse glutathione conjugation of aldehyde 139(LC-MS
data)
To generate the DCL with the aldehyde 137 we randomly chose ten commercially
available aryl hydrazides (Scheme 2.8).  This library consisted of eight acyl and two





that this diverse set of acylhydrazones bearing a common chloronitrobenzaldehyde
moiety would be able to access the hydrophobic pocket at the GST binding site under
suitable conditions. The hydrazones would also have similar UV absorption
properties to allow sensitive detection at a common wavelength.
Scheme 2.8 Acyl hydrazone DCL based on ten selected hydrazides
To increase the potency of our DCL components we envisaged the use of aldehyde
138 as our core scaffold to generate an n x 1 DCL with the same hydrazides 141a-j
(Scheme 2.9). We expected the glutathione motif of the aldehyde to act as an
‘anchor’ at the enzyme G-site thereby enabling the exploration of the H-site with the
different hydrazide fragments.28 The γ-glutamyl residue of GSH is known to be
critical for its binding at the hydrophilic G-site forming a number of key hydrogen
bonds and salt bridges.29-31 This ‘anchoring’ approach uses GSH in a passive role in
strict contrast to previous work in the Greaney group based on conjugate addition of
thiols to enones,4 where GSH played an active role in the reversible reaction used to
generate the DCL (Scheme 2.10).
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Scheme 2.10 The concept of anchoring. A: reversible Michael addition of thiols to
enones where GSH plays an active role as a reactant. B: the GS- moiety is
‘anchored, on to the enzyme G-site.
2.4.2 Synthesis of glutathione conjugated aldehyde
Glutathione conjugate aldehyde 138 was synthesised by an SNAr reaction under basic
conditions in a 1:1 mixture of MeCN and water as outlined in Scheme 2.11.  After 48
hours stirring at room temperature, the yellow solution was washed with diethyl
ether, concentrated and then purified by preparative HPLC.
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Scheme 2.11 Synthesis of glutathione conjugates aldehyde scaffold
2.4.3 Aniline catalysis of acylhydrazone formation
To optimize aniline catalysis for our DCLs we first decided to probe if any
substituents on aniline improve the rate of hydrazone formation and exchange. We
measured the initial rates of reaction between aldehyde 138 (0.5 mM, aqueous) and
hydrazide 141b (0.5 mM, DMSO) for a range of aniline derivatives A, B, C, D E, G
and imidazole F (Figure 2.3). The reactions performed at ambient temperature in
ammonium acetate buffer (0.1M, pH 6.2, 10% DMSO) were monitored by UV-
HPLC at 254 nm. Interestingly anilines (at concentrations of 10 mM) with electron-
donating groups (A,B,C,D) increase the rate with t1/2 values < 30 minutes while
electron-poor and sterically hindered anilines show t1/2 values >> 10 hours ( graph in
Figure). Since rate enhancement by aniline (A) was comparable to p-methoxyaniline
(B) and aniline is more compatible with aqueous environments we decided to use




































Figure 2.3 Substituted anilines and imidazole catalysing the acyl hydrazone
reaction: the graph shows the formation of hydrazone 143b over time at a reactant
concentration of 0.5mM each in 0.1M ammonium acetate buffer (pH 6.2) in the
absence and in the presence of different substituted anilines (10 mM). Peak integrals
from RP-HPLC traces (254 nm) used to measure the fraction of hydrazones formed
2.4.4 Effect of aniline concentration on DCL equilibration: Single hydrazone
formation
We further optimised the amount of the nucleophilic catalyst required by measuring
the rate of formation of hydrazone 143b at different aniline concentrations ranging
from 0.01-10 mM (Figure 2.4). At individual reactant concentrations of 1 mM in
buffer at pH 6.2, significant acceleration of the reaction rate was observed for aniline
concentrations in the range 1-10 mM. A low concentration of 0.01 mM aniline did
not significantly alter the rate in comparison to the uncatalysed reaction. These
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relatively large concentrations of aniline achieve high rates of hydrazone formation






























Figure 2.4 Effect of aniline concentration on the catalysis of acylhydrazone
reaction: the graph shows the formation of hydrazone 143b over time at a reactant
concentration of 1mM each in 0.1M ammonium acetate buffer (pH 6.2) in the
absence and in the presence of different concentrations of aniline. Peak integrals
from RP-HPLC traces (254 nm) were used to measure the fraction of hydrazones
formed
2.4.5 Effect of aniline concentration on DCL equilibration: 3 membered DCL
To adapt the results of our studies on aniline catalysis of acylhydrazone formation for
generating biocompatible DCLs we started with small 3-membered DCLs formed
from aldehyde 138 and an equivalent each of the hydrazides 141b, 141e and 141f.
We set up the libraries at four different aniline concentrations (10 mM, 1 mM, 0.1
mM, and 0.01 mM) in buffer/DMSO mixtures (pH 6.2) and analysed their
composition by HPLC over different time intervals. The libraries with 10 mM and 1
mM aniline equilibrated very quickly with a steady state composition achieved in
less than 4 hours (Figures 2.5a and b).
On the other hand the DCLs with 0.1 mM and 0.01 mM aniline took 24 – 48 hours
for complete equilibration (Figures 2.5c and d). We thus concluded that an optimum
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catalyst concentration in the millimolar range would be required for generating our
larger hydrazone DCLs.
Figure 2.5.a DCL with 10 mM aniline.  Conditions: Aldehyde (1 mM), hydrazides
(2 mM each) in NH4OAc Buffer (100 mM, pH = 6.2) containing 10% DMSO. DCLs
were analysed by HPLC at 254 nm.
Figure 2.5.b DCL with 1 mM aniline. Conditions: Aldehyde (1 mM), hydrazides
(2 mM each) in NH4OAc Buffer (100 mM, pH = 6.2) containing 10% DMSO. DCLs
were analysed by HPLC at 254 nm.
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Figure2.5.c DCL with 0.1 mM aniline.  Conditions: Aldehyde (1 mM), hydrazides
(2 mM each) in NH4OAc Buffer (100 mM, pH = 6.2) containing 10% DMSO. DCLs
were analysed by HPLC at 254 nm.
Figure2.5.d DCL with 0.01 mM aniline. Conditions: Aldehyde (1 mM), hydrazides
(2 mM each) in NH4OAc Buffer (100 mM, pH = 6.2) containing 10% DMSO. DCLs
were analysed by HPLC at 254 nm.
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2.4.6 Optimising a 10-membered acylhydrazone library
To understand the effect of aniline on a 10-membered DCL we mixed aldehyde 138
(Scheme 2.8), with 2.5 equivalents of each of the ten aryl hydrazides 141a-h at room
temperature in 15% DMSO. This stoichiometry was chosen to keep the reaction
pseudo-first order with respect to the aldehyde so that during the course of the
reaction there would not be any shortage of one hydrazide which could introduce a
bias in the library.5 The excess hydrazides used would also limit side reactions
between the aldehyde and amino residues of the enzyme. The concentrations of the
library constituents (20 μM for the aldehyde and 50 μM for each of the ten
hydrazides) were optimised to be within the solubility limits of the hydrazone
products formed under the aqueous conditions used since any insoluble compounds
can act as thermodynamic traps for the DCL. 32-36
Equilibration at pH 6.2 was slow, and only two of the ten possible hydrazones could
be observed by HPLC after 1 hour (Figure 2.6, DCL A). Despite the presence of
excess amounts of the hydrazides there was a significant amount of free aldehyde
138 present throughout the reaction. Equilibrium, as attested by a steady state
composition for the library, was attained after five days of incubation. However, a far
higher rate of equilibration was observed in the presence of 10 mM aniline as
expected from our previous results. The aldehyde 138 could not be detected by
HPLC following initial mixing, while a distribution of acyl hydrazones was observed
after initial mixing and LC sampling. Complete equilibration of the ten components




Figure 2.6 Aniline-catalysed acyl hydrazone DCL. Conditions: Aldehyde (20 M),
hydrazides (50 M each) in NH4OAc Buffer (50 mM, pH = 6.2) containing 15%
DMSO. Library A is run in the absence of aniline while library B is run in the
presence of aniline (10 mM). DCLs analysed by HPLC at 254 nm.
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2.4.7  Reversibility of the DCLs
To ensure adaptive behaviour under the optimised conditions we probed the
reversibility of our DCLs. We generated the same library from a different starting
composition, hydrazone 142g plus the nine other hydrazides in the presence of 10
mM aniline. An identical equilibrium distribution was observed within 18 hours,
indicating true thermodynamic equilibrium (Figure 2.7). We confirmed the
reversibility of the DCL by a second experiment in which an excess of hydrazide
141b was added to the pre-equilibrated DCL. As expected this resulted in a large
amplification of the corresponding acyl hydrazone 142b (Figure 2.8).
Figure 2.7 Proof of reversibility of aniline-catalysed acylhydrazone DCLs:
constitute DCL from alternative starting point, hydrazone 142g. Conditions:
hydrazone 142g (20 M), aniline(10 mM) hydrazides (50 M each) in NH4OAc
Buffer (50 mM, pH = 6.2) containing 15% DMSO. DCLs analysed by HPLC at 254
nm.
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Figure 2.8 Proof of reversibility of aniline-catalysed acylhydrazone DCLs: addition
of excess component (141b)(15L, 10mM, DMSO)  to DCL at equilibrium. DCLs
analysed by HPLC at 254 nm.
2.4.8  Protein activity under DCL conditions
Having established nucleophilic catalysis of the DCLs under conditions suitable for
biomolecular stability we decided to confirm if our target proteins retained
conjugation activity under these optimised conditions. The two recombinant GST
isozymes SjGST and hGSTP1-1 were expressed and purified by Anne Caniard from
the Campopiano group. We incubated the proteins for two days with 20 mM aniline
at pH 6.2 measuring their conjugation activity by a CDNB assay in 24 hour intervals.
Both the isoforms retained considerable acitivity under the DCL conditions with 20
mM aniline (Figure 2.9).
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Figure 2.9 Activity of SjGST and hGSTP1-1 under aniline-catalysed DCL
conditions.(Assessed using GSH-CDNB conjugation assay. The samples with aniline
had 15% DMSO in ammonium acetate buffer (50 mM, pH 6.2)
To further confirm the biological compatibility of our optimised aniline-catalysed
DCL conditions we synthesised 3-member DCLs (143b, 143e, 143f) in the presence




equilibrium composition of the library is not affected in the presence of large
amounts of these biologically relevant nucleophiles.
Figure 2.10 Biological compatibility of acylhydrazone DCLs: 3-membered DCLs
equilibrated in the presence of 10 mM GSH and 10 mM Lysine. No change in
composition in comparison to the blank DCL
2.4.9  Protein-templated DCLs
Having optimised biocompatible aniline-catalysed conditions, our next step was to
introduce proteins into our DCLs. We synthesized the acyl hydrazone DCL (Scheme
2.8) in the presence of one equivalent each (with respect to the scaffold aldehyde) of
the proteins, SjGST and hGST P1-1. These mixtures were equilibrated over 12 hours
followed by the addition of base to freeze the library composition. The protein
template was removed by centrifugation and the samples analysed by HPLC. The
DCL constituted in the presence of SjGST clearly amplified thiophene hydrazone
142g while hGSTP1-1 amplified t-butylphenyl hydrazone 142c (Figure 2.11). A
control experiment with one equivalent of BSA instead of GST produced no
amplification which confirmed that the enzymes were responsible for the selection
(Figure 2.12). We re-synthesized the hydrazones in order to assay them but poor
solubility prevented the determination of accurate IC50 values at the higher
concentrations necessary to assay weak binding compounds.
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Figure 2.11 GST-templated DCLs. Conditions: GST (1 equiv), aldehyde (20 μM),
hydrazides (50 μM) and aniline (10 mM) in NH4OAc Buffer (50 mM, pH = 6.2)
containing 15% DMSO for 16 h. DCLs analysed by HPLC at 254 nm.
Figure 2.12 BSA-templated DCLs. Conditions: BSA (1 equiv), aldehyde (20 μM),
hydrazides (50 μM) and aniline (10 mM) in NH4OAc Buffer (50 mM, pH = 6.2)
containing 15% DMSO for 16 h. DCLs analysed by HPLC at 254 nm.
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To probe if the amplified components were bound in the target H-region of the
enzyme’s active site we performed conjugation experiments with GSH. Conjugation
of GSH to the aryl chloride group in hydrazones 142g via SNAr substitution is a slow
reaction at pH 6.2, taking several days. In the presence of catalytic amounts of
SjGST, however, rapid formation of the SNAr conjugation adduct for hydrazone
143g was observed at pH 6.2 (Scheme 2.12).  The amplified hydrazone can thus act
as a substrate for SjGST and binds in the targeted H-site.
Scheme 2.12 Demonstration of thiophene hydrazone 142g as a GST substrate:
Conjugation catalysed by SjGST analysed by LCMS at 254 nm.
2.4.10  Protein-templated glutathione conjugate DCLs
Anticipating that the GS-conjugate hydrazones would solve the solubility problem
and also to capitalize on increased molecular recognition by the protein,29-31 we
synthesized DCLs using GS-conjugated aldehyde 138 and the same ten hydrazides as
employed previously (Scheme 2.13). A higher concentration of the aldehyde (50












μM) could be used in this case due to better solubilities of the conjugate hydrazones.
Equilibration of the libraries was complete in 6 hours, compared to 4 days in the
absence of aniline, and each of the ten acyl hydrazones were identified by LC-MS.
Clear amplifications could be observed for DCLs equilibrated in the presence of both
GST targets: in each case the same hydrazide fragment was selected as the best
binder, thiophene (143g for SjGST and t-butylphenyl (143c) (Figure 2.13). Both
components were amplified to over 300% of their concentrations in the blank DCL,
at the expense of nearly all other competing hydrazones (graph in Figure 2.13).
Additionally, the anisyl sulfonylhydrazone 143j underwent ca. 100% amplification
using hGST P1-1 as the only other positively selected component. Significant
reduction in equilibrium concentrations occurred for hydrazones 143b, f and i in the
case of SjGST and hydrazones 143f, g and i for hGSTP1-1. Whether the protein was
present from the beginning of the reaction or was added to a pre-equilibrated library
had no bearing on the final equilibrium distribution of the products which indicates
true thermodynamic selection.
Scheme 2.13 Protein-templated conjugate acylhydrazone DCL
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143a 143i+f 143b 143g143h 143e 143j 143d 143c
Figure 2.13 GST-templated DCLs. Conditions: GST (1 equiv), aldehyde (50 μM),
hydrazides (50 μM) and aniline (10 mM) in NH4OAc Buffer (50 mM, pH = 6.2)
containing 15% DMSO for 16 h. The graph illustrates changes in DCL component
concentration for blank versus SjGST versus hGST P1-1 DCLs. DCLs analysed by
HPLC at 254 nm.
Two different control experiments confirmed that the proteins were responsible for
the observed divergent amplification effects. Firstly, synthesizing the DCL in the

















































presence of one equivalent of BSA produced no amplification (Figure 2.14). Again,
both protein-templated DCLs synthesised in the presence of a large excess (100 μM)
of the non-selective GST inhibitor ethacrynic acid (73) 37-39 yielded no amplification
(Figure 2.15). No component amplification is observed in the presence of the
inhibitor which indicates that the GST active site is saturated by the ethacrynic acid
and cannot influence the DCL equilibrium composition.
Figure 2.14 Control Experiment: BSA-templated DCL shows no amplification
Conditions: BSA (1 equiv), aldehyde (50 μM), hydrazides (50 μM) and aniline (10
mM) in NH4OAc Buffer (50 mM, pH = 6.2) containing 15% DMSO for 16 h. DCLs
analysed by HPLC at 254 nm.























                                                       Ethacrynic acid (73)
Figure 2.15 Control experiment for GSH conjugate DCL in the presence of excess
ethacrynic acid (100 μM). DCLs analysed by HPLC at 254 nm.
2.4.11 Acyl hydrazone DCLs targeting Y7F mutant of SjGST
As a further control experiment and to see if a functionally disabled enzyme would
exhibit the same selectivity towards our DCL systems, we choose a Y7F mutant of
SjGST as our protein target. Anne Caniard from the Campopiano group expressed
and purified the mutant. The protein is catalytically inactive due to the lack of a
crucial tyrosine residue which has been replaced with a phenylalanine.40 The
conserved Tyr7 active site residue is known to play a critical role in GSH
conjugation for the Sj class of GSTs, stabilising the GSH thiolate anion through H-
bonding from the phenol group. We observed essentially zero activity with this
mutant in CDNB conjugation versus the wild type SjGST (Figure 2.16, protein
activity measured by Anne Caniard). However, SjGST Y7F proved equally effective
in controlling DCL composition, showing a clear preference for the same thiophene
derivative 143g as was amplified by the wild type SjGST (Figure 2.16). This

































provided crucial evidence that no kinetic selection operates in the DCLs templated
by the enzymes.
Time (s)


















SjGST Y7F (0.15 nM)
SjGST (0.15 nM)
Figure 2.16 GSH-conjugate DCL templated by SjGST-Y7F mutant amplifying
acylhydrazone143g. DCL conditions: Y7F SjGST mutant (1 equiv), aldehyde (50
μM), hydrazides (50 μM) and aniline (10 mM) in NH4OAc Buffer (50 mM, pH = 6.2)
containing 15% DMSO for 16 h. The graph shows comparative CDNB assays
between SjGST WT and SjGST Y7F. The mutant catalytic activity was reduced to
1.7%.(Assay performed by Anne Caniard)
2.4.12 Isothermal titration calorimetry
We first confirmed that the amplified ligands are bound to SjGST and hGST P1-1
using isothermal titration calorimetry (ITC).  Hydrazones 143a-j were synthesised

























and purified by RP-HPLC (> 95% purity). Isothermal calorimetry was performed on
the hydrazones by Anne Caniard in collaboration Prof. Alan Cooper at University of
Glasgow. This technique is well established in studying protein-ligand interactions
and has unique advantages: simultaneous determination of all associated parameters
like the stoichiometry (N), the dissociation constant (K), the enthalpy (ΔH) and the
entropy (ΔS) changes involved in the binding event.41-43 These parameters for the
amplified ligands 143c and 143g bound to SjGST and hGSTP1-1 are given in Table
2.1.  Data for scaffold structure 138 is also given for comparison. The enzyme-ligand
binding interactions are exothermic with Kd values of compounds 143c and 143g an
order of magnitude less than the aldehyde 138 which suggests that inhibitor structure
has been extended by the hydrazide fragments. The stoichiometry N, gave values
around 2 as expected for two ligands per dimer of the protein.
143c 143c143g 143g 138
Table 2.1 ITC data for Ligand binding to SjGST and hGSTP1-1 (See section 2.6.13
for ITC plots)
2.4.13 Inhibition assays
In collaboration with A. M. Caniard and D.J Campopiano we studied the inhibitory
activity of the hydrazones towards SjGST and hGST P1-1 using the standard CDNB
conjugation assay. The hydrazones were synthesized and purity checked by HPLC (>
95%). The IC50 values for the different hydrazones are listed in Table 2.2.
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Table 2.2 IC50 data (μM). Assay conditions: To 360 μl well were added phosphate
buffer (255 μl, 0.1 M, pH 6.8), GST (15 μl, 0.15 mg.ml-1) and inhibitor (15 μl, 0.2 to
200 μM). The solution was mixed well and after incubation at 25 °C for 5 min,
CDNB (15 μl, 40 mM) and GSH (15 μl, 40 mM) were added quickly and mixed.
Absorbance was measured at 340 nm, 25 °C for 5 min.
All hydrazones exhibited moderate inhibition in the micromolar range for both the
isoforms but the values were slightly higher for hGSTP1-1 (59 to 126 μM) compared
to SjGST (22 to 63 μM). However, most gratifyingly the DCC selected hydrazones
were most active for both the isoforms. Hydrazone 143g showed and IC50 value of 22
μM for SjGST, the lowest among all the library members. Among the 4 conjugates
tested against hGSTP1-1 t-butylphenyl hydrazone 143c had the lowest IC50 (57 μM).
Thus, by extending the scaffold structure 138 through an adaptive DCC selection
process we were able to increase potency by ten-fold for SjGST (279 to 22 μM)
relative to the starting anchored aldehyde. A similar six-fold rise in potency was
observed for hGSTP1-1 (331 to 57 μM).
Hydrazone SjGST hGST P1-1
138 279 ± 23 331 ± 20
143a 24 ± 1 ND
143b 40 ± 2 ND
143c 50 ± 3 57 ± 2
143d 26 ± 1 ND
143e 36 ± 2 ND
143f 61 ± 3 ND
143g 22 ± 1 87 ± 3
143h 34 ± 1 119 ± 8
143i 37 ± 1 84 ± 4
143j 25 ± 1 ND
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Table 2.3 Ki data (μM)
The Ki values for the selected hydrazones are given in Table 2.3 and are very close to
the Kd values determined by ITC. Interestingly, both the compounds gave slightly
higher values when assayed against CDNB in comparison to GSH which binds at the
G-site. Both the conjugates showed similar affinities towards the G-sites of the
enzymes which is expected for two compounds sharing a common glutathione-
tagged nitro-benzene fragment.
2.4.14 Molecular modelling studies
To understand the selectivity of our GST isozymes towards the two hydrazone
inhibitors 143c and 143g, we carried out a molecular modeling study in collaboration
with Dr. Ruth Brenk and Dr. Torsten Luksch (Dundee University).  Available GST
structures in the protein data bank (PDB) sharing more than 40% sequence identity to
the target SjGST crystal structure (1M9A) were analysed and from these 38
structures that contained a bound, GSH-based ligand, were selected. Upon aligning
these structures, it was observed that the GSH portions overlaid well, being bound in
very similar conformations in the highly conserved G-sites. However, the conjugate
hGST P1-1 SjGST
CDNB GSH CDNB GSH
Km (mM) 0.59 ± 0.043 0.38 ± 0.03 4.08 ± 0.80 0.29 ± 0.01
Ki
143g (M) 13.96 ± 0.78 7.19 ± 0.42 12.82 ± 0.68 5.25 ± 0.23
Ki
143c (M) 10.66 ± 0.67 6.61 ± 0.42 18.58 ± 1.05 6.33 ± 0.27
IC50
143g (M) 88 ± 28 22 ± 2
IC50
143c (M) 59 ± 9 49 ± 10
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hydrophobic parts of the ligands exhibited great diversity in their bound
conformations emphasising the highly promiscuous nature of the enzyme H-site
(Figure 2.17a).
A closer examination of the superimposed crystal structures identified the GSH
conjugate of 1,2-epoxy-3-(p-nitrophenoxy)propane (EPNP) 144 bound to cGST M1-
1 (PDB code 1C72) as the ligand that projected into the H-site with the most similar
geometry to the energy-minimized structure of hydrazone 143g (Figure 2.17b)
Figure 2.17 a: Superposition of a selection of GST ligands from the PDB.
b:Conformation of the GST-bound EPNP ligand 144 as found in the crystal structure
(PDB code 1c72, green carbon atoms), relative to the energy minimized structure of
compound 143g (pink carbon atoms).(Modelling performed by Torsten Luksch and
Ruth Brenk, University of Dundee)
Based on an analysis of the bound ligand 144 a binding model for SjGST was
generated with thiophene hydrazone 143g and for hGST P1-1 with t-butyl hydrazone
143c (Figure 2.18). The interactions in the generated binding modes for SjGST in















2.18b) between the glutathione moiety and the proteins are identical to those reported
in previous publications.38,44 We predict the hydrazone group of 143g forms
hydrogen bonds to R103 and Q204 in SjGST, and equivalent interactions are
observed for 143c in complex with hGST P1-1. Residue V161 in SjGST and I161 in
hGST P1-1 make hydrophobic interactions in our models with the ligands 143g and
143c.
The thiophene hydrazone fits easily in the SjGST binding pocket with only minor
side chain adjustments necessary (RMSD 0.3 Å between model and crystal structure
template). The t-butylphenyl group, however, would lead to a steric clash and
requires some degree of induced fit in order to bind. Induced fit is also required to
accommodate this ligand in the hGST P1-1 pocket, but in this case the binding mode
could be stabilized by additional lipophilic interactions of the t-butyl group with
Y103, H162 and I161. The amino acid residues at the H-sites of SjGST and
hGSTP1-1 are not highly conserved and could play a major role in determining
ligand selectivity.
Figure 2.18 Modelling of amplified ligands at the GST active site. a: Model of 143g
bound to SjGST. b: Model of 143c bound to hGST P1-1.The binding pocket surfaces
are shown in light blue and key amino acids as blue sticks. The ligands are
represented in salmon pink, with atoms coloured by type. Hydrogen bonds of the
conjugated ligand parts are shown as yellow dotted lines. c: The EPNP–cGST M1-1
crystal structure (PDB code 1c72). The binding pocket surface is shown in raspberry
pink and key amino acids as red sticks. The ligand is represented in green, with
atoms coloured by type.Hydrogen bonds of the conjugated ligand parts are shown as





We have established that adaptive DCls based on reversible synthesis of acyl
hydrazones can be compatible with protein targets by using aniline as a nucleophilic
catalyst. The pH (= 6.2) used was optimised as a fine balance between facile
reversibility of the acylhydrazone reaction and protein stability. We then used these
DCLs as a tool to explore the promiscuous H-sites of various GST isoforms. The two
GST isoforms showed divergent amplification effects with the selected hydrazones
showing increased inhibitory activity of over one order of magnitude from the starting
GSH-tagged nitro-benzaldehyde 138, thus validating the approach in the context of
protein–ligand discovery. The library size was kept deliberately small in order to fully
characterise equilibrium distributions and quantify amplifications by separation.
Isoform-specific ligands could still be identified from such small libraries which indicate
the inherent strength of this evolutionary method. The fine structural features that define
the active sites of the enzymes that discriminate between the selected hydrazones are still
unclear; a deeper understanding would require structural determination of the complexes
of GST: GS-hydrazone conjugates.
2.6 Experimental
2.6.1 General Methods
Melting points are uncorrected. 1H and 13C NMR spectra were recorded on a Brüker
dpx360 (360 MHz) instrument and calibrated to residual solvent peaks: proton
(CDCl3 7.26 ppm) and carbon (CDCl3 77.0 ppm). The
1H data is presented as
follows: chemical shift (in ppm on the δ scale), multiplicity (s=singlet, d=doublet,
t=triplet, q=quartet, m=multiplet), the coupling constant (J, in Hertz) and integration.
The 13C data is reported as the ppm on the δ scale followed by the interpretation.
Electrospray and electron impact high resolution mass spectrometry was performed
by the EPSRC National Mass Spectrometry Service Centre, Swansea, using a
Finnigan MAT 900 XLT double focusing mass spectrometer. The data is recorded as
the ionisation method followed by the calculated and measured masses. TLC was
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performed on Merck 60F254 silica plates and visualised by UV light and/or
anisaldehyde or potassium permanganate stains. All chemicals were purchased from
a chemical supplier and used as received. Analytical and preparative HPLC were
performed on instruments from Agilent Technologies, UK.
2.6.2 Synthesis of glutathione conjugate aldehyde 138
In a 50 mL round bottom flask, 4-chloro-3-nitrobenzaldehyde 137 (500 mg, 2.69
mmol) and glutathione (994 mg, 3.23 mmol) were dissolved in a mixture of
water/MeCN (15 mL, 1:1). Sodium carbonate (343 mg, 3.23 mmol) was then added
and the reaction mixture stirred at room temperature for 48 hours. The yellow
coloured solution was washed with diethyl ether (2  15 mL) and the aqueous phase
was concentrated to approximately 5 mL followed by purification by RP-HPLC. The
column fractions were pooled together and lyophilized to give the pure compound as
a yellow fluffy solid. (66% yield). 1H NMR (d6-DMSO, 360 MHz) δH 9.81 (s, 1H),
8.52 (d, J = 1.7 Hz, 1H), 7.99 (dd, J = 8.5, 1.7 Hz, 1H), 7.67 (d, J = 8.5 Hz, 1H),
4.67 (dd, J = 9.2, 4.7 Hz, 1H), 3.67-3.60 (m,4H) 3.30 (dd, J = 14.0, 9.30 Hz, 1H)
2.49-2.37 (m, 1H) 2.02 (dd, J = 14.6, 7.07 Hz, 1H).13CNMR (d6-DMSO, 90 MHz),
193.3, 176.5, 175.2, 174.3, 171.4, 146.0, 144.0, 133.7, 133.0, 128.1 (2 signals
overlapping), 54.4, 52.0, 43.7, 33.8, 31.7, 26.5. HRMS calcd for [C17H21N4O9S]
























2.6.3 General method for the synthesis of hydrazones
In a 25 mL round bottom flask the aldehyde 137(1 eq) and the corresponding
hydrazide (1.1 eq) were dissolved in 10 ml of a mixture of 7:3 water/acetonitrile
followed by the addition of a few drops of glacial acetic acid. The resulting yellow
precipitate was filtered off, washed many times with cold ether and cold water and
then lyophilized to give the pure hydrazone.
2.6.4 General method for the synthesis of glutathione conjugated hydrazones
In a 25 mL round bottom flask the glutathione conjugated aldehyde 138 (1 eq) and
the corresponding hydrazide (1.1 eq) were dissolved in 10 mL of a mixture of 7:3
water/acetonitrile followed by the addition of a few drops of glacial acetic acid. The
resulting yellow precipitate was filtered off, washed many times with cold ether and
then lyophilized to give the pure hydrazone as solid.
Representative hydrazone data
Hydrazone 142c:
White solid (81%yield). 1H NMR δH 12.13 (s, 1H), 8.52 (s, 1H) 8.41 (s, 1H), 8.08 (d,
J = 8.2 Hz, 1H), 7.89 (m,  3H), 7.58 (d, J = 8.3 Hz, 2H), 1.34 (s, 9H) 13CNMR (d6-
DMSO, 90 MHz), 163.2, 155.0, 147.9, 144.0, 135.0, 132.2, 131.5, 130.2, 127.5,
125.6, 125.3, 123.5, 34.7, 30.9. HRMS calcd for [C18H19ClN3O3] (MH
+) requires m/z




























White solid (76% yield). 1H NMR δH 12.21 (s, 1H), 8.51 (s, 1H), 8.39 (d, J = 1.9 Hz,
1H), 8.05 (dd, J = 8.4, 2.02 Hz, 1H), 8.01 (d, J = 0.9 Hz, 1H), 7.87 (d, J = 8.4 Hz,
1H), 7.38 (s, 1H), 6.75 (dd, J = 3.5, 1.7 Hz, 1H). 13CNMR (d6-DMSO, 90 MHz),
154.3, 147.9, 146.2, 144.2, 134.9, 132.2, 131.5, 125.7, 123.5, 115.5, 112.2. HRMS
calcd for [C12H9ClN3O4] (MH

























2.6.5 GST-catalysed glutathione conjugation of aldehydes 137 and 139
Reduced glutathione (20 µL, 10mM aqueous), aldehyde 137 (20 µL, 10mM, DMSO)
and SjGST (10 µL, 180 µM in KPhos buffer 0.1 M, pH  6.8) were added to
ammonium acetate buffer (950 µL 50mM , pH 7.2) at room temperature. After 2
hours the protein was removed by filtration using a 10000 MWCO filter (Vivaspin)
and the resulting solution analysed by LC-MS. The experiment was repeated with
aldehyde 139.
2.6.6 Aniline catalysis of acylhydrazone formation: effect of substituted anilines
Aldehyde 138 (10 μL, 50 mM aqueous) and hydrazide 141b (10 μL, 50 mM, DMSO)
were added to a mixture of DMSO (90 μL) and ammonium acetate buffer (890 μL
0.1M, pH 6.2). The fraction of the hydrazone (143b) formed at room temperature
was monitored by HPLC over 8 hours. (HPLC conditions: Column: Luna 5 μ C18(2)
30 mm × 4.6 mm, flow rate 1mL min-1, wavelength 254 nm, temperature 30 oC,
gradient H2O / MeCN (0.01% TFA) from 95% to 30% over 4 min). The
concentrations and fractions were calculated from the integrals of the HPLC signals
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at 254nm. The reaction was then performed in the presence of substituted anilines
and imidazole respectively (10 mM).
2.6.7 Effect of aniline concentration on DCL equilibration: Single hydrazone
formation
Aldehyde 138 (20 μL, 50 mM aqueous) and hydrazide 141b (20 μL, 50 mM, DMSO)
were added to a mixture of DMSO (80 μL) and ammonium acetate buffer (880 μL
0.1M, pH 6.2). The fraction of the hydrazone (143b) formed at room temperature
was monitored by HPLC over 8 hours. (HPLC conditions: Column: Luna 5 μ C18(2)
30 mm × 4.6 mm, flow rate 1mL min-1, wavelength 254 nm, temperature 30 oC,
gradient H2O / MeCN (0.01% TFA) from 95% to 30% over 4 min). The reaction was
then performed under increasing concentrations of aniline (0.01-10 mM). The
concentrations and fractions were calculated from the integrals of the HPLC signals
at 254nm.
2.6.8 Effect of aniline concentration on DCL equilibration: 3 membered DCL
Hydrazides 141b, 141e and 141f (3 × 20 μL, 0.1 M, DMSO), aldehyde 138 (20 μL,
50 mM, aqueous) and aniline (20 μL, 500 mM, DMSO) were added to a mixture of
DMSO (10 μL) and ammonium acetate buffer (880 μL, 0.1M, pH 6.2). The DCL
with an aniline concentration of 10mM was allowed to stand at room temperature
with occasional shaking and monitored periodically by HPLC to establish the
composition until the relative concentrations of the hydrazones became constant.
(HPLC conditions: Column: Luna 5 μ C18(2) 30 mm × 4.6 mm, flow rate = 1 mL
min-1, wavelength 254 nm, temperature 30 oC, gradient H2O / MeCN (0.01% TFA)
from 95% to 80% over 1.5 min then to 60% over 3 min and eventually to 30% over
1.5 min). The DCL was then re-generated and analysed over time in the presence of
1 mM, 0.1 mM and 0.01 mM aniline concentration respectively.
2.6.9 Aniline catalysis of ten-membered hydrazone library
The ten hydrazides 141a-j (10  5 µL, 10 mM, DMSO), aldehyde 137 (2 µL, 10
mM, DMSO) and aniline (10 µL, 1 M, DMSO) were added to a mixture of DMSO
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(93 µL) and ammonium acetate buffer (845 µL, 50 mM, pH 6.2). The DCL was
allowed to stand at room temperature with occasional shaking and monitored
periodically by HPLC to establish the blank composition till the relative populations
of the hydrazones became constant. The pH of all samples was raised to 8 by the
addition of NaOH (15 µL, 1M, aqueous). LC-MS verified that each of the expected
hydrazones was present in the DCL (HPLC conditions: Column: Luna 5 µ C18(2) 30
mm  4.6 mm and Luna 5 µ C18(2) 50 mm  4.6 mm in sequence, flow rate : 1mL
min-1, wavelength 254nm, temperature 23oC, gradient H2O/ MeCN (0.01% TFA)
from 95% to 80% over 6 min then to 45% over 30 min and eventually to 5% over 5
min).  The DCL was then re-synthesised in the absence of aniline and the HPLC







Figure 2.19 MS data for DCL based on aldehyde 137, indicating that all the
expected ten acylhydrazones are present
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2.6.10  Protein activity under DCL conditions
Reduced glutathione (20 µL, 10mM aqueous), CDNB (20 µL, 10mM, DMSO) and
SjGST (10 µL, 180 µM in KPhos buffer 0.1 M, pH  6.8) were added to ammonium
acetate buffer (950 µL 50mM , pH 7.2). The fraction of glutathione conjugate formed
was monitored in every five minute intervals by HPLC over 50 min. (HPLC
conditions: Column: Luna 5 µ C18(2) 30 mm x 4.6 mm, flow rate 1mL min-1,
wavelength 254nm, temperature 23oC, gradient H2O/ MeCN (0.01% TFA) from 95%
to 20% over 4 min)
SjGST (10 µL , 180 µM in KPhos buffer 0.1 M, pH  6.8) was added to a mixture of
DMSO (110 µL) ,ammonium acetate buffer (840 µL 50mM, pH 6.2) and aniline (20
µL, 1M, DMSO) Two samples of these mixtures were incubated at 25oC over 24
hours and 48 hours respectively. To both the samples were added reduced
glutathione (20 µL, 10mM aqueous) and CDNB (20 µL, 10mM, DMSO) and the
fraction of glutathione conjugate formed was measured for five minute intervals.
2.6.11 Protein-templated DCLs
SjGST (111 µL, 180 µM, in potassium phosphate buffer 0.1 M, pH 6.8), the ten
hydrazides 141a-j (10  5 µL, 10 mM, DMSO), the aldehyde 137 (2 µL, 10 mM,
DMSO) and aniline (10 µL, 1 M, DMSO) were added to a mixture of DMSO (93
µL) and ammonium acetate buffer (734 µL, 50 mM, pH 6.2). The DCL was allowed
to stand at room temperature with occasional shaking over 12 hours. The pH of the
sample was raised to 8 by the addition of NaOH (15 µL, 1M, aqueous) and the
protein was removed by ultrafiltration using a 10000 MWCO filter (Vivaspin).
HPLC analysis was performed and the traces were compared with the blank
composition.  (HPLC conditions: Column: Luna 5 µ C18(2) 30 mm  4.6 mm and
Luna 5 µ C18(2) 50 mm  4.6 mm in sequence, flow rate : 1mL min-1, wavelength
254nm, temperature 23oC, gradient H2O/ MeCN (0.01% TFA)  from 95% to 80%
over 6 min then to 45% over 30 min and eventually to 5% over 5 min).
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The DCL composition was identical regardless of whether the SjGST was present
from the beginning, or added after pre-equilibration, but equilibration took more than
24 hours in the latter case.
For the hGST P1-1 templated library, the ten hydrazides 141a - j (10  5 µL, 10 mM,
DMSO), the aldehyde 137 (2 µL, 10 mM, DMSO), aniline (10 µL, 1 M, DMSO) and
hGST P1-1 (100 µL, 200 µM, in potassium phosphate buffer 0.1 M, pH 6.8) were
added to a mixture of DMSO (93 µL) and ammonium acetate buffer (734 µL, 50
mM, pH 6.2). After equilibration over 12 hours the DCL was analysed using HPLC.
Control experiments were performed using the same equivalents of BSA in place of
GST.
2.6.12  Protein-templated glutathione conjugate DCLs
To establish the blank DCL composition the ten hydrazides 141a - j (10  5 µL,
10mM, DMSO), aldehyde 138 (5 µL, 10mM, aqueous) and aniline (10 µL, 1M,
DMSO) were added to a mixture of DMSO (96 µL) and ammonium acetate buffer
(839 µL, 50 mM, pH 6.2). The DCL was allowed to stand at room temperature with
occasional shaking and monitored periodically by HPLC to establish the blank
composition till the relative populations of the hydrazones became constant. The pH
of all samples was raised to 8 by the addition of NaOH (15 µL, 1M, aqueous). LC-
MS verified that each of the expected hydrazones was present in the DCL. (HPLC
conditions: Column: Luna 5 µ C18(2) 50 mm  4.6 mm and Luna 5 µ C18(2) 250
mm  4.6 mm in sequence, flow rate : 1mL min-1, wavelength 254nm, temperature
23oC, gradient H2O/ MeCN (0.01% TFA)  from 95% to 5% over 40 min).
For resynthesizing the DCL in the presence of the protein SjGST (278 µL, 180 µM,
in potassium phosphate buffer 0.1 M, pH 6.8), the ten hydrazides 141a - j (10  5
µL, 10mM, DMSO), aldehyde 138 (5 µL, 10 mM, DMSO) and aniline (10 µL, 1 M,
DMSO) were added to a mixture of DMSO (96 µL) and ammonium acetate buffer
(561 µL, 50 mM, pH 6.2). The DCL templated by hGST P1-1 was synthesized by
adding the ten hydrazides 141a - j (10  5 µL, 10mM, DMSO), the aldehyde 138 (5
µL, 10 mM, DMSO), aniline (10 µL, 1 M, DMSO) and hGST P1-1 (250 µL, 200
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µM, in KPhos buffer 0.1 M, pH 6.8) to a mixture of DMSO (96 µL) and ammonium
acetate buffer (589 µL, 50 mM, pH 6.2). The DCLs were allowed to stand at room
temperature over 12 hours after which the pH was raised to 8 by the addition of
NaOH (15 µL, 1M). The protein was filtered off using a centrifuge filter of MWCO
10000 followed by analysis of the filtrate by HPLC using similar conditions to those
listed above. Control experiments were performed using the same equivalents of
BSA in place of GST. For the control experiments with ethacrynic acid 73, a large
excess (100μM) of the inhibitor was used. A similar DCL was equilibrated in the







Figure 2.20 MS data for DCL based on aldehyde 138, indicating that all the
expected ten acylhydrazones are present
2.6.13 Isothermal Titration Calorimetry (experiments carried out by Anne
Caniard)
Isothermal titration calorimetry (ITC) was carried out in collaboration with Pr. Alan
Cooper and the Glasgow Biological Microcalorimetry Facility. The ITC
measurements were performed on a VP-ITC calorimeter (Microcal Inc Northampton,
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USA) at 25 °C. SjGST and hGSTP1-1 were dialysed against a 0.1 M potassium
phosphate buffer, pH 6.8. The final dialysis buffer was used to make up the ligand
solution as well as for instrument calibration and baseline controls.  Hydrazones 143c
and 143g were dissolved and titrated in 10 % DMSO. The concentrations of SjGST
and hGSTP1-1 (approximately 20 μM) were determined by measuring the absorption
at 280 nm and the concentrations of ligands were approximately 30 times higher.
The reactants SjGST and hGSTP1-1 were place in the 2 mL sample chamber and
143c or 143g in the syringe. A typical ITC measurement consisted of a first control
injection of 1 μl followed by 29 successive injections of 10 μL for 20 s with a 3 min
interval between each injection.
Raw data were collected, corrected for ligand heats dilution, and the peaks generated
integrated using ORIGIN software (Microcal Inc) by plotting the values in
microcalories against the molar ratio of injectant to reactant within the cell. Data
were fitted using the one single-site binding model. From the dissociation constant
KD and the reaction enthalpy value ΔH, the change in free Gibbs energy (ΔG°) and
entropy change (ΔS°) can be calculated using the equation ΔG° = -RT ln(1/KD) = ΔH
- TΔS° where R is the universal gas constant and T the absolute temperature.
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Figure 2.21a ITC of SjGST in the presence and in the absence of 143g. Top: Heats
of injection of 276 μM 143g into a cell containing 17 μM SjGST. Bottom: Data from
the upper panel integrated and plotted as a function of the molar ratio of 143g after
subtraction of heats generated by injection of 276 μM 143g into buffer
Figure 2.21b  ITC of SjGST in the presence and in the absence of 143c. Top: Heats
of injection of 604 μM 143c into a cell containing 21 μM SjGST. Bottom: Data from
the upper panel integrated and plotted as a function of the molar ratio of 143c after
subtraction of heats generated by injection of 604 μM 143c into buffer.
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Figure 2.21c ITC of hGSTP1-1 in the presence and in the absence of 143c. Top:
Heats of injection of 680 μM 143c into a cell containing 20 μM hGSTP1-1. Bottom:
Data from the upper panel integrated and plotted as a function of the molar ratio of
143c after subtraction of heats generated by injection of 680 μM 143c into buffer.
Figure 2.21d ITC of hGSTP1-1 in the presence and in the absence of 143g. Top:
Heats of injection of 598 μM 143g into a cell containing 20 μM hGSTP1-1. Bottom:
Data from the upper panel integrated and plotted as a function of the molar ratio of
143g after subtraction of heats generated by injection of 598 μM 143g into buffer.
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2.6.14 Inhibition Assays (Experiments carried out jointly with Anne Caniard )
Inhibition assays were carried out on a Perkin Elmer Wallac VICTOR2™ 1420
Multilabel counter UV-visible 96 well-plate spectrophotometer. To 360 μl well were
added phosphate buffer (255 μl, 0.1 M, pH 6.8), GST (15 μl, 0.15 mg.ml-1) and
inhibitor (15 μl, 0.2 to 200 μM). The solution was mixed well and after incubation at
25 °C for 5 min, CDNB (15 μl, 40 mM) and GSH (15 μl, 40 mM) were added
quickly and mixed. Absorbance was measured at 340 nm, 25 °C for 5 min.
The Ki values with respect to both GSH and CDNB were determined. Inhibition
kinetics were studied at 8 different, fixed concentrations of either GSH or CDNB (8,
16, 31, 63, 125, 250, 500 and 1000 μM) with variable concentrations of the inhibitor
(2 to 200 μM). Data were collected and analysed using SigmaPlot® software.
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143g (μM)
Figure 2.22a  Inhibition of SjGST by 143g using GSH and CDNB as substrates. The
IC50 value is the concentration of inhibitor giving 50% inhibition of enzyme activity.
Data are the mean ± standard deviation of triplicate experiments.
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143c (μM)
Figure 2.22b Inhibition of hGSTP1-1 by 143c using GSH and CDNB as substrates.
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2.6.15  Protein Synthesis (Anne Caniard and Dominic Campopiano)
Expression and purification of SjGST
The SjGST construct pGEX-6P-1 (GE Healthcare) was used to transform E. coli
expression strain BL21 (DE3) and grown on LB/ampicillin (100 μg/ml) agar plates.
One colony was used to inoculate 200 ml of LB broth containing ampicillin (100
μg/ml) and grown overnight at 37 °C with agitation (250 rpm). The 200 ml overnight
culture was used to inoculate 3 L of LB broth and grown to an OD600 of 0.6 at 37 °C
and then induced with 0.1 mM IPTG for 3 to 4 hours at 37 °C. Cells were harvested
by refrigerated centrifugation at 5 000 x g for 10 min immediately after induction.
Cell pellets were frozen and stored at -20 °C until required.
The SjGST expressing pellet was resuspended (4 ml/g wet cell pellet) in buffer
binding buffer (50 mM Tris-HCl, pH 7) containing one protease inhibitor cocktail
tablet (EDTA-free). The resuspended pellet was sonicated for 15 min (30 s on / 30 s
off) on ice and was then centrifuged at 27 000 x g for 30 min at 4 °C to remove
insoluble debris. The supernatant was filtered through a 0.45 μm membrane prior to
chromatography at 4 °C. The cell lysate was loaded onto a 20 ml GSTPrep FF 16/10
column (GE Healthcare) previously equilibrated with binding buffer. The column
was then washed with 5 column volumes of binding buffer before elution using a
linear gradient of 0-100 % elution buffer (50 mM Tris-HCl, 10 mM glutathione, pH
8) over 5 column volumes. Fractions were analysed by SDS-PAGE and those
containing sjGST were pooled and applied onto a 320 ml HiPrep Sephacryl S-200
HR column (GE Healthcare) pre-equilibrated with a 0.1 M potassium phosphate
buffer containing 150 mM NaCl, pH 6.8. The column was then eluted with one
column volume of the same buffer. Fractions containing sjGST were pooled and
dialysed against 4 L of a 0.1 M potassium phosphate buffer, pH 6.8 at 4 °C.
Expression and purification of hGSTP1-1
Overexpression of His6-Tagged hGSTP1-1 was carried out by transforming E. coli
BL21 (DE3) cells with the pET15b/hGSTP1 vector. A single colony was added to
200 ml LB supplemented with ampicillin (100 μg.ml-1) and grown overnight at 37 °C
and 250 rpm. This seed culture was then used to inoculate 3 L of fresh LB medium
and grown to OD600 of 0.6 before induction with isopropyl thio-β-D-glalactoside
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(IPTG, 1.0 mM final concentration) for 3 to 4 hours at 37 °C and 250 rpm. The cells
were then harvested by centrifugation (5000 x g for 15 min at 4 °C) and stored at -20
°C. Cells overexpressing His6-hGSTP1-1 were resuspended in binding buffer (50
mM Tris- HCl, 0.5 M NaCl, 5 mM imidazole, pH 7, 4 ml per gram of wet cell paste)
with one protease inhibitor cocktail tablet (EDTA-free) and disrupted by sonication
(15 pulses of 30 s at 30 s intervals) at 4 °C. The cell debris were removed by
centrifugation at 27 000 x g for 30 minutes at 4 °C, after which the supernatant was
filtered through a 0.45 μm membrane prior to chromatography. The cell lysate was
loaded onto a 5 ml HisTrap™ HP column (GE Healthcare) previously equilibrated
with the same binding buffer. The column was then washed with 5 column volumes
of binding buffer before the bound material was eluted using a linear gradient of 0-
100 % elution buffer (50 mM Tris- HCl, 0.5 M NaCl, 0.5M imidazole, pH 8) over 20
column volumes at 4 °C. Fractions were analysed by SDS-PAGE and those
containing hGSTP1-1 were pooled and applied onto a 320 ml HiPrep Sephacryl S-
200 HR column (GE Healthcare) pre-equilibrated with a 0.1 M potassium phosphate
buffer containing 150 mM NaCl, pH 6.8. The column was then eluted with one
column volume of the same buffer. Fractions containing hGSTP1-1 were pooled and
dialysed against 4 L of a 0.1 M potassium phosphate buffer, pH 6.8 at 4 °C.
Site-directed mutagenesis, expression and purification of SjGST-Y7F
Plasmid pGEX-6P-1 was used as a template in the site-directed mutagenesis
experiment. The Y7F-For (5’ -TCCCCTATACTAGGTTTTTGGAAAATTAAG- 3’)
and Y7F-Rev (5’ -CTTAATTTTCCAAAAACCTAGTATAGGGGA- 3’)
oligonucleotides were used to change the TAT codon in the SjGST sequence to TTT,
so that the tyrosine amino-acid residue was replaced by a phenylalanine (SjGST-
Y7F). Mutations were performed by using Stratagene site-directed mutagnenesis kit.
Each reaction contained plasmid DNA (5 μl), 10x reaction buffer (5 μl), primer-
forward (1 μl), primer-reverse (1 μl), dNTP mix (1 μl), distilled water (final volume
50 μl) and Pfu DNA polymerase 2.5 u / μl (1 μl). The amplification parameters were
as follow: an initial DNA denaturation at 95 °C for 2 min followed by 16 cycles of
denaturation at 95 °C for 30 sec, annealing at 55 °C for 60 sec and extension at 68 °C
for 7 min. One microliter (5 U) of DpnI restriction enzyme was added to the PCR
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product and incubated at 37 °C for 2 h. The ligation product was used to transform
competent E. coli cells DH5α (DE3). The new mutated plasmid was confirmed by
DNA sequencing and named pGEX-6-P1-Y7F.
The pGEX-6P-1-Y7F construct was used to transform E. coli expression strain BL21
(DE3) and grown on LB/ampicillin (100 μg/ml) agar plates. One colony was used to
inoculate 200 ml of LB broth containing ampicillin (100 μg/ml) and grown overnight
at 37 °C with agitation (250 rpm). The 200 ml overnight culture was used to
inoculate 3 L of 2 x YT broth and grown to an OD600 of 0.6 at 37 °C and then
induced with 0.1 mM IPTG for 5 to 6 hours at 30 °C. Cells were harvested by
refrigerated centrifugation at 5 000 x g for 10 min immediately after induction. Cell
pellets were frozen and stored at -20 °C until required.
The Y7F SjGST expressing pellet was resuspended (4 ml/g wet cell pellet) in buffer
binding buffer (50 mM Tris-HCl, pH 7) containing one protease inhibitor cocktail
tablet (EDTA-free). The resuspended pellet was sonicated for 15 min (30 s on / 30 s
off) on ice and was then centrifuged at 27 000 x g for 30 min at 4 °C to remove
insoluble debris. The supernatant was filtered through a 0.45 μm membrane prior to
chromatography at 4 °C. The cell lysate was loaded onto a 20 ml GSTPrep FF 16/10
column (GE Healthcare) previously equilibrated with binding buffer. The column
was then washed with 5 column volumes of binding buffer before elution using a
linear gradient of 0-100 % elution buffer (50 mM Tris-HCl, 10 mM glutathione, pH
8) over 5 column volumes. Fractions were analysed by SDS-PAGE and those
containing sjGST were pooled and applied onto a 320 ml HiPrep Sephacryl S-200
HR column (GE Healthcare) pre-equilibrated with a 0.1 M potassium phosphate
buffer containing 150 mM NaCl, pH 6.8. The column was then eluted with one
column volume of the same buffer. Fractions containing sjGST were pooled and
dialysed against 4 L of a 0.1 M potassium phosphate buffer, pH 6.8 at 4 °C.
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2.6.16 Protein analyses (Anne Canniard and Dominic Campopiano)
Mass spectrometry analyses of the pure enzymes gave the molecular masses of the
Schistosoma japonicum GST as 28 434 Da, the His6- hGSTP1-1 as 25 629 Da and
the SjGST-Y7F as 28 410 Da in good agreement with the predicted values of 28 428
Da, 25 630 Da and 28 412 Da for the monomers, respectively. The concentration of
SjGST, hGSTP1-1 and SjGST-Y7F were determined using a Bradford assay. The
proteins were stored in a 0.1 M potassium phosphate buffer, pH 6.8 containing 20 %
glycerol (v/v) at -20 °C.
2.6.17 Molecular modelling (carried out by Dr. Ruth Brenk and Dr. Torsten Luksch
at Dundee University).
Ligand alignment: The superposition of glutathione S-transferase ligands was
carried out by using Relibase+3.0.0.45 First, a search was performed to find binding
sites that share a sequence identity between 40 % and 100 % to the target GST
crystal structure 1m9a. The resulting 38 structures with bound ligand were
superimposed by using binding site residues only. Finally, the ligands from the
superimposed structures were extracted and visually analysed.
Binding mode prediction with Moloc46
The SjGST crystal structure (pdb code: 1m9a SjGST – S-hexyl-GSH complex) and
the hGST P1-1 – GSH complex crystal structure (pdb code: 6gss) were used as
starting conformations for binding mode generation. The glutathione groups of the
synthesized ligands were mapped onto the glutathione groups of the ligands bound to
the crystal structures. The hydrophobic hydrazone groups of the synthesized ligands
were oriented towards the cavity, lying at the end of the S-hexyl site, as observed for
the EPNP ligand bound to cGSTM1-1 (pdb code 1c72). In the next step, the protein
in complex with the modeled ligand was minimized, considering the ligand as fully
flexible. For the protein all residues were kept rigid, except the amino acids that
define the pocket at the end of the S-hexyl site (R103, V106, V161, V162, Q204 for
SjGST and R100, Y103, I161, H162, N204 for hGST P1-1).
127
2.7  Notes and References
1 Ramström, O.; Lehn, J.-M. ChemBioChem 2000, 1, 41-48.
2 Otto, S.; Furlan, R. L. E.; Sanders, J. K. M. J. Am. Chem. Soc. 2000, 122,
12063-12064.
3 Shi, B.; Greaney, M. F. Chem. Commun. 2005, 886-888.
4 Shi, B.; Stevenson, R.; Campopiano, D. J.; Greaney, M. F. J. Am. Chem. Soc.
2006, 128, 8459-8467.
5 Huc, I.; Lehn, J.-M. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 2106-2110.
6  Cousins, G. R. L.; Poulsen, S.-A.; Sanders, J. K. M. Chem. Commun. 1999,
1575-1576.
7     Bunyapaiboonsri, T.; Ramström, O.; Lohmann, S.; Lehn, J.-M.; Peng, L.;
Goeldner, M. ChemBioChem 2001, 2, 438-444.
8     Bunyapaiboonsri, T.; Ramström, H.; Ramström, O.; Haiech, J.; Lehn, J.-M. J.
Med. Chem. 2003, 46, 5803-5811.
9     Kalia, J.; Raines, R.T. Angew, Chem. Int. Ed. 2008, 47, 7523-7526.
10   Furlan R. L. E.; Ng, Y.-F.; Otto S.; Sanders, J. K. M. J. Am. Chem. Soc. 2001,
123, 8876–8877.
11 Roberts, S. L.; Furlan, R. L. E.; Cousins G. R. L.; Sanders, J. K. M. Chem.
       Commun. 2002, 938-939.
12   Liu, J.; West, K. R.; Bondy, C. R.; Sanders J. K. M. Org. Biomol. Chem. 2007,
5, 778-786.
13   Poulsen, S.A. J. Am. Soc.Mass Spectrom. 2006, 17, 1074-1080.
14   Skene, W.G.; Lehn, J.-M. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 8270-
       8275.
15   Cordes, E. H.; Jencks, W. P. J. Am. Chem. Soc. 1962, 84, 826-831.
128
16   Dirksen, A.; Dirksen, S.; Hackeng, T. M.; Dawson, P. E. J. Am. Chem. Soc.
2006, 128, 15602–15603.
17 Dirksen, A.; Dawson, P. E. Bioconjugate Chem. 2008, 19, 2543-2548.
18   Dirksen, A.; Hackeng, T. M.; Dawson, P. E. Angew, Chem. Int. Ed. 2006, 45,
7581- 7584.
19   Hayes, J. D.; Flanagan, J. U.; Jowsey, I. R. Annu. Rev. Pharmacol. Toxicol.
2005, 45, 51-88.
20 Mahajan, S.; Atkins, W. M. Cell. Mol. Life Sci. 2005, 62, 1221-1233.
21 Armstrong, R.N. Curr. Opin. Chem. Biol. 1998, 2, 618-623.
22    Mannervik, B.; Danielson, U.H. CRC Crit. Rev. Biochem. 1988, 23, 283-
337.
23    Dirr, H.; Reinemer, P.; Huber, R. Eur. J.Biochem. 1994. 220, 645-661.
24    Dourado, D.F.; Fernandes, P.A.; Mannervik, B.; Ramos, M. J. Chemistry
2008, 14, 9591-9598.
25    Ketley, J.N.; Habig, W.H.; Jakoby, W.B. J. Biol. Chem, 1975,250, 8670-
       8673.
26    Tew, K. D. Cancer Res. 1994, 50, 6449-6454.
27    Jao, S.-C.; Chen, J.; Yang, K.; Li, W.-S. Bioorg. Med. Chem. 2006 14, 304-
        318.
28    Lyon, R. P.; Hill, J. J.; Atkins, W. M. Biochemistry 2003, 42, 10418-10428.
29    Armstrong, R.N. Chem. Re.s Toxicol. 1997, 10, 2-18.
 30 Manoharan, H.T.; Gulick, A.M.; Puchalski, R.B.; Servais, A.L.; Fahl, W.E.
J.Biol.Chem. 1992, 267, 18940-18945.
31    Stenberg, G.; Board, P.G.; Mannervik, B.. FEBS Lett. 1991, 293, 153-155.
129
32    Corbett, P. T.; Leclaire, J.; Vial, L.; West, K. R.; Wietor, J-L.; Sanders, J. K.
M.; Otto, S. Chem. Rev. 2006,106, 3652-3711.
33 Dynamic Combinatorial Chemistry in Drug Discovery, Bioorganic
Chemistry, and Materials Science; edited by Miller, B.L.; Wiley, 2010.
34    Otto, S.; Furlan, R. L. E.; Sanders, J. K. M. Curr. Opin. Chem. Biol. 2002, 6,
321-327.
35 Cheeseman, J.D.; Corbett, A. D.; Cleason, J.L.; Kazlauskas, R.J. Chem. Eur.
 J. 2006, 11, 1708-1716.
36    Rowan, S.J.; Cantrill, S.J.; Cousins, G.R.L.; Sanders, J.K.M.; Stoddart, J.F.
Angew, Chem. Int. Ed. 2002, 41, 898-906.
37   Zhao, G.; Yu,T.; Wang,R.; Wang, X.; Jing,Y. Bioorg. Med. Chem. 2005, 13,
4056-62.
38   Oakley, A.J.; Rossjohn, J.; Lo Bello, M.; Caccuri, a.M.; Fredrici, G.; Parker,
 M.W. Biochemistry 1997, 36, 576-585.
39   Oakley, A.J.; Lo Bello, M.; Mazetti, A.P.; Fredrici,G.; Parker, M.W. FEBS
 Lett. 1997, 419, 32-36.
40   Andújar-Sánchez, M.; Smith, A.W.; Clemente-Jimenez, J. M.; Rodriguez-
Vico, F.; Las Heras-Vazquez, F. J.; Jara-Pérez, V.; Cámara-Artigas, A.
Biochemistry 2005, 44, 1174-1183.
41 Campoy, A. Z.; Freire, E. Nature Protocols 2006, 1,186-191.
42 Ladbury, J.E.; Klebe, G.; Freire, E. Nature Reviews:Drug Discovery 2010, 9,
23-27.
43 Pierce, M.M.; Raman, C.S.; Nall, B.T. Methods 1999, 19, 213-221.
44 Cardoso, R. M.; Daniels, D. S.; Bruns, C. M.; Tainer, J. A. Proteins 2003, 51,
137-146.
130
45 Bergner, A.; Günther, J.; Hendlich, M.; Klebe, G.; and Verdonk, M. Biopolymers
2001, 61, 99-110.






Recently, dynamic combinatorial libraries (DCLs)1,2 have become an invaluable tool
in the study of emergent behaviour of complex interacting molecular networks, an
area now referred to as systems chemistry.3-10  The choice of the reversible reaction
is a fundamental design parameter in constructing dynamic combinatorial libraries:
the exchange process has to be rapid under mild conditions and should not interfere
with molecular recognition events which aid library evolution. Reactions commonly
used include disulfide, hydrazone/imine and thioester exchange. More complex
systems which combine two or more reversible reactions to generate multilevel
dynamic libraries with increased diversity have appeared recently in literature.11-18
One of the earliest examples using multiple equilibria was reported by Miller and
Klekota in 1999 (Scheme 3.1). They used imine formation and transition- metal
complexation between Zn(II) ions and salicylaldimines to generate DCLs targeting
DNA.11
Scheme 3.1 DCLs using imine formation and metal complexation targeting DNA
Sanders, Otto and co-workers have reported a double- level ‘communicating’ library
based on the simultaneous exchange of disulfide and thioester bonds in aqueous
solution at neutral pH (Scheme 3.2).13 A complex system involving three exchange
processes incorporating disulfides, imines and metal coordination has also been
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reported by Nitschke.15 Furlan et al have combined disulfide, hydrazone and
thioester chemistry in a single system. 19
Scheme 3.2 A double- level ‘communicating’ DCL based on the simultaneous
exchange of disulfide and thioester bonds
Orthogonal double-level libraries, in which one exchange process is selectively
activated while the other is kinetically slow under the conditions employed, are an
interesting variation. Hydrazone exchange coupled orthogonally to ligand exchange
around a cobalt ion has been reported by Eliseev and Lehn.12 In this system ligand
exchange at the terpyridine cobalt(II) centre can be turned off by oxidation of the
metal to cobalt(III) while imine exchange can be turned off by increasing the pH.
The combinations of imine and nitrone exchange 20 and hydrazone exchange with
azobenzene photoisomerisation 21 have also been reported.
A recent addition to the list of orthogonal dynamic processes is the combination of
disulfide and hydrazone exchange in a single system reported simultaneously by Otto
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and Furlan (Scheme 3.3).17,18 The hydrazone exchange process is exclusively
activated under acidic conditions while basic conditions switch on the disulfide
exchange. The unique features of this orthogonal system has been used by Leigh et al
to construct a synthetic small molecule walker that can walk down a track.22,23 This
fully synthetic model of the cellular motor protein kinesin emphasizes the advantages
of orthogonal dynamic covalent chemistry and led us to focus on the discovery of
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Scheme 3.3 Reactions involved in hydrazone and disulfide exchange
We have explored here the combination of hydrazone exchange24-30 and Michael
addition of thiols to enones as two independently addressable reversible reactions in
a single aqueous dynamic system. Previous work in the Greaney group had
established reversible Michael addition of thiols to enones under mild aqueous
conditions as a tool for DCC (Scheme 3.4).31 The reaction was successfully applied
later to generate DCLs targeting the enzyme glutathione-S-transferase (GST) in an
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attempt to identify best-binding ligands.32 The reaction equilibrates rapidly under
basic conditions but is extremely slow at low pH. On the other hand, fast hydrazone
exchange requires acid catalysis (pH < 4) and the reaction is irreversible under basic
conditions.33,34 The aim of this project was to establish the optimal experimental
conditions required to facilitate orthogonal use of these reversible reactions in
aqueous solution.
Scheme 3.4  Reversible Michael addition of thiols to enones
3.2  Results and Discussion
In order to prove the orthogonality of the two reactions, we began by preparing a
DCL of mono-functional components that would set up independent acyl
hydrazone and conjugate addition exchange processes (Figure 3.1). We chose the
enone ethacrynic acid (EA) 73 as our Michael acceptor, previously used by us for
targeting the enzyme GST. EA derivatives equilibrate quickly (< 3 hr) with the
cellular thiol glutathione (GSH) 69 at pH 8.31,32
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Figure 3.1 DCL components: the orthogonal DCL is built from one aldehyde, three
hydrazides, two thiols and one enone.
3.2.1 pH dependence of conjugate addition of thiols to enones
For the orthogonal DCL to be successful, we require thiol conjugate addition to
out-compete any intefering conjugate addition of the nucelophilic hydrazides.35
To probe this chemoselectivity, we mixed enone 73 with two samples containing
a mixture of GSH (69), and hydrazide 141b under acidic and basic conditions. At
pH 8.5 Michael adduct 146 formed immediately even though an equivalent of
hydrazide was present in the system. Under acidic conditions (pH 3.5), however,
no reaction occurred and the concentration of 73 remained constant over 6 hours.
An experiment with L-cysteine (145) instead of thiol 69 gave similar results
(Figure 3.2).
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Figure 3.2 pH dependence of conjugate addition of thiols to enones Ethacrynic acid
(73) (5 µL, 10 mM, DMSO), glutathione (69) (10 µL, 10 mM, aqueous) and
hydrazide 141b (10 µL, 10 mM, DMSO) were added to a mixture of DMSO (185 µL)
and ammonium acetate buffer (790 µL, 50 mM, pH 8.5) Another sample was
similarly set up in ammonium acetate buffer pH 3.5 and monitored over 6 hours.
Ethacrynic acid (73) (5 μL, 10 mM, DMSO) and L-cysteine (145) (10 μL, 10 mM,
aqueous) were added to a mixture of DMSO (195 μL) and ammonium acetate buffer
(790 μL, 50 mM, pH 8.5). All samples were analysed by HPLC at 254 nm.
2
138
3.2.2 pH dependence of hydrazone formation
The  reverse chemoselectivity, that of hydrazides out-competing thiols in reaction
with aldehydes, was confirmed by the same protocol where Michael acceptor 73
is replaced by aldehyde 137. Rapid hydrazone formation was observed at pH 3.5
even in the presence of the thiol.  No hydrazone was formed in 30 minutes at pH
8.5 though small amounts of 142b were detected when the system was allowed to
react over 6 hours (Figure 3.3)
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Figure 3.3  pH dependence of hydrazone formation. Aldehyde 137 (5 µL, 10 mM,
DMSO), glutathione (69) (10 µL, 10 mM, aqueous) and hydrazide 141b (10 µL,
10 mM, DMSO) were added to a mixture of DMSO (185 µL) and ammonium
acetate buffer (790 µL, 50 mM, pH 3.5). A similar sample was mixed at pH 8.5.
All samples analysed by HPLC at 254 nm.
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3.2.3 Monofunctional conjugate addition-hydrazone exchange
To adapt these results to a pH-addressable DCL that could be switched between
the two channels of reactivity, we mixed together aldehyde 137 (50 µM), enone
73 (50 µM), GSH 69 (100 µM) and hydrazides 141b and 141g (100 µM each) in
20% DMSO-ammonium acetate buffer (50 mM, pH 8.5) at room temperature.
Analysing the mixture by HPLC at 254 nm after 30 min showed the formation of
the EA-GSH conjugate 146 as expected while no detectable amounts of
hydrazones 142b and 142g were found. (Figure 3.4, trace A1) We then
deactivated the conjugate addition by switching the pH to 3.5 with acetic acid. An
immediate sampling of the mixture by HPLC indicated appreciable formation of
the hydrazones 142b and 142g and a reduction in the aldehyde 137 (Figure
3.4,trace A2). Subsequent analysis over time showed that the electron-deficient
aldehyde 137 was completely consumed in less than 6 hours with the hydrazones
142b and 142g in a dynamic equilibrium (Figure 3.4, trace A3). Importantly, no
change in concentrations of the Michael acceptor 73 or the adduct 146 was
observed throughout this period indicating that the reaction was switched off.
We next decided to probe the reversibility of the hydrazone exchange under
conditions where the Michael addition is deactivated (Figure 3.4, traces B1 – B5).
We added excess of hydrazide 141f (200 µM) to the sample mixture from
experiment A at pH 3.5. Hydrazone 142f started forming immediately though no
free aldehyde was detected in the system.( Figure 3.4, traces B1-B3) Monitoring
the mixture over 12 hours showed that the hydrazone equilibrium had shifted
considerably towards 142f with substantially lower amounts of 142b and 142g
now present. Most gratifyingly, the concentrations of Michael acceptor 73 and
adduct 146 remained constant throughout. Further, adding the more reactive thiol
cysteine (145, 100 µM) to the mixture under the same acidic conditions did not
change the concentration of 73 over 2 hours nor did the Michael adduct 147
appear, confirming the true orthogonality of the double-level dynamic system
(Figure 3.4, trace B5).36,37
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Figure 3.4 pH-Addressable DCL. HPLC UV (254 nm) traces showing the elution profile of
DCL product components derived from aldehyde 137 and enone 73. The starting thiols and
hydrazides are very polar and elute close to the solvent front in each analysis. The HPLC
analysis is split into three cumulative phases: Phase A examines the pH orthogonality of
hydrazone formation and conjugate addition. Phase B demonstrates adaptation of the
hydrazone DCL in the presence of frozen conjugate addition components. Phase C
demonstrates re-activation of conjugate addition chemistry following the switching off of
hydrazone exchange.
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To probe the pH dependence of the hydrazone exchange we switched on the
Michael addition by titrating the same mixture with 5M aqueous NaOH to pH 8.5.
As expected, cysteine adduct 147 formed rapidly within 30 min with no EA 73
detected in the mixture after 2 hours (Figure 3.4, trace C2). Additionally, the
concentrations of the hydrazones 142b, 142g and 142f remained constant over 6
hours of reaction (Figure 3.4, traces C3-C4).
3.2.4 Bifunctional conjugate addition-hydrazone exchange
Orthogonal dynamic covalent chemistry using hetero-bifunctional molecules
would be a significant advantage in generating complex molecular structures. To
explore the utility of hydrazone formation and conjugate addition in this context
we prepared a DCL based around the bifunctional thio-hydrazide 148 (Figure
3.5).
Figure 3.5 Bifunctional DCL components
142
Initially, compound 148 (100 µM) was added to a mixture of aldehyde 137 and
enone 73 (50 µM each) in aqueous buffer containing 20% DMSO at pH 8.5.
Monitoring the reaction over a period of 12 hours showed a progressive decrease
in the concentration of 73 while the amount of aldehyde 137 remained constant
throughout. The expected conjugate adduct 149 eluded detection under our LC
conditions, although its presence in the mixture was confirmed by mass
spectrometry (m/z = 437). Indirect evidence of its formation was obtained when
we switched the pH of the mixture to 3.5. The concentration of aldehyde 137
rapidly reduced over time and significant amount of compound 151 was formed,
indicating that the initial conjugate addition of the thiol in 148 had taken place
(Figure 3.6).
143
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Figure 3.6 Orthogonal conjugate addition and hydrazone formation with Compound
148. Ethacrynic acid (73) (20 µL, 10 mM, DMSO), aldehyde 137 (20 µL, 10 mM,
DMSO), and thiohydrazide 148 (40 µL, 10 mM, aqueous), were added to a mixture
of DMSO (760 µL) and ammonium acetate buffer (3160 µL, 50mM, pH 8.5).
Analysed byHPLC over 12 hr at 254 nM. The pH of the mixture was then switched to






To confirm pH control over a more complex system we mixed together aldehyde
137, enone 73, GSH 69, thiohydrazide 148 and hydrazide 141b (all 100 µM each)
in DMSO-ammonium acetate buffer at pH 8.5 (Figure 3.7). Acidification and
sampling after 5 min showed rapid formation of GSH adduct 146 had occurred,
with adduct 149 not being detected as in the previous case. Analysis after 6 hours
showed adduct 146 in stasis, the complete disapperance of aldehyde 137 and the
formation of  hydrazones 142b, 150 and 161.


































Figure 3.7 Bifunctional DCL. Ethacrynic acid (73) (10 µL, 10 mM, DMSO),
aldehyde 137 (10 µL, 10 mM, DMSO), glutathione (69) (10 µL, 10 mM, aqueous),
thiohydrazide (148) (10 µL, 10 mM, DMSO) and  hydrazide 141b (10 µL, 10 mM,
DMSO) were added to a mixture of DMSO (160 µL) and ammonium acetate buffer
(790 µL, 50 mM, pH 8.5). Analysed by HPLC at 254 nM over 6 hours followed by a
switch in pH of to 3.5 and then monitored by HPLC periodically over 6 hours.
3.2.5 Disulfide formation under conjugate addition conditions
To confirm if disulfide formation competes with conjugate addition under our
conditions we mixed together thiol 152 with ethacrynic acid 73 (100 µM each) at
pH 8.5. Though thiol 152 formed the disulfide when it was on it own at pH 8.5, in
the presence of the enone, Michael addition was extremely fast with almost no
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Figure 3.8 Disulfide formation under conjugate addition conditions. 4-thiobenzoic acid
(152) (10 µL, 10 mM, MeCN), was added to a mixture of MeCN (190 µL) and ammonium
acetate buffer (800 µL, 50 mM, pH 8.5 and analysed by HPLC at 254 nM over 48 hours.
Again, 4-thiobenzoic acid (152) (10 µL, 10 mM, MeCN), and ethacrynic acid (73) (5 µL, 10
mM, MeCN) and were added to a mixture of MeCN (185 µL) and ammonium acetate buffer
(800 µL, 50 mM, pH 8.5 and analysed by HPLC at 254 nM over 48 hours.
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3.3 Conclusion
In conclusion, we have established that thiol conjugate addition and hydrazone
formation exhibit very high levels of orthogonality when combined in a single
DCC experiment. The DCLs are formed in aqueous solution and are easily
controlled by simple pH change, undergoing cyclical de- and re-activation
according to pH regime. From a design perspective, our work contrasts with
recent orthogonal DCL systems in using exchange processes that feature




All DCL components for the current study were purchased from commercial
chemical companies with the exception of compound 148, an initial sample of which
was obtained from Max von Delius (Leigh group). HPLC analysis was carried out on
a Agilent 1100 machine. Column: Luna 5 µ C18(2) 50 mm  4.6 mm, flow rate :
1mL min-1, wavelength 254 nm, temperature 30 oC, gradient H2O / MeCN (0.01%
TFA)  from 95% to 5% over 30 min then back to 95% over 3 min.
3.4.2 pH Dependence of conjugate addition of thiols to enones
Ethacrynic acid (73) (5 µL, 10 mM, DMSO), glutathione (69) (10 µL, 10 mM,
aqueous) and hydrazide 141b (10 µL, 10 mM, DMSO) were added to a mixture of
DMSO (185 µL) and ammonium acetate buffer (790 µL, 50 mM, pH 8.5) in 2 mL
screw-cap vial. The sample composition was analysed by HPLC at 254 nM over 6
hours. Another sample was similarly set up in ammonium acetate buffer pH 3.5 and
monitored over 6 hours.
Ethacrynic acid (73) (5 μL, 10 mM, DMSO) and L-cysteine (145) (10 μL, 10 mM,
aqueous) were added to a mixture of DMSO (195 μL) and ammonium acetate buffer
(790 μL, 50 mM, pH 8.5) in a 2 mL screw-cap vial. The sample composition was
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analysed by HPLC at 254 nM after 30 min. Another sample was similarly set up in
ammonium acetate buffer at pH 3.5 and monitored.
3.4.3 pH Dependence of hydrazone formation
Aldehyde 137 (5 µL, 10 mM, DMSO), glutathione (69) (10 µL, 10 mM, aqueous)
and hydrazide 141b (10 µL, 10 mM, DMSO) were added to a mixture of DMSO
(185 µL) and ammonium acetate buffer (790 µL, 50 mM, pH 8.5) in a 2 mL screw-
cap vial. The sample composition was analysed by HPLC at 254 nM over 6 hours.
Another sample was similarly set up in ammonium acetate buffer pH 3.5 and
monitored over 6 hours.
3.4.4 Monofunctional conjugate addition-hydrazone exchange
Experiment A
Ethacrynic acid (73) (20 µL, 10 mM, DMSO), aldehyde 137 (20 µL, 10 mM,
DMSO), glutathione (69) (40 µL, 10 mM, aqueous) and hydrazides 141b and 141g
(40 µL each, 10 mM, DMSO) were added to a mixture of DMSO (680 µL) and
ammonium acetate buffer (3160 µL, 50 mM, pH 8.5) in a 7 mL screw-cap vial. The
sample was analysed by HPLC at 254 nM after 30 min. The sample mixture was
immediately titrated with glacial acetic acid to pH 3.5 and monitored by HPLC
periodically over 6 hours.
Experiment B
An excess of hydrazide 141f (80 µL, 10 mM, DMSO) was then added to the sample
mixture from Experiment A (pH 3.5) and the composition analysed by HPLC over a
period of 6 hours. L-cysteine (145) (40 µL, 10 mM, aqueous) was then added to the
mixture at pH 3.5 and the composition was monitored periodically over 2 hours.
Experiment C
The pH of the sample mixture from Experiment B was now switched to 8.5 by
titrating with aqueous 5M NaOH followed by periodic HPLC analysis over 6 hours.
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3.4.5 Orthogonal conjugate addition and hydrazone formation with compound
148
Ethacrynic acid (73) (20 µL, 10 mM, DMSO), aldehyde 137 (20 µL, 10 mM,
DMSO), and thiohydrazide 148 (40 µL, 10 mM, aqueous), were added to a mixture
of DMSO (760 µL) and ammonium acetate buffer (3160 µL, 50mM , pH 8.5) in a 7
mL screw-cap vial. The sample was analysed by HPLC at 254 nM over 12 hours.
The pH of the mixture was then switched to 3.5 by titration with glacial acetic acid
and analysed over 6 hours by HPLC.
3.4.6 Bifunctional conjugate addition-hydrazone exchange
Ethacrynic acid (73) (10 µL, 10 mM, DMSO), aldehyde 137 (10 µL, 10 mM,
DMSO), glutathione (69) (10 µL, 10 mM, aqueous), thiohydrazide (148) (10 µL, 10
mM, DMSO)  and  hydrazide 141b (10 µL, 10 mM, DMSO) were added to a mixture
of DMSO (160 µL) and ammonium acetate buffer (790 µL, 50 mM, pH 8.5) in a 2
mL screw-cap vial. The sample was analysed by HPLC at 254 nM over 6 hours. The
pH of the sample mixture was then switched to 3.5 by titration with glacial acetic
acid and monitored by HPLC periodically over 6 hours.
3.4.7 Disulfide formation under conjugate addition conditions
4-thiobenzoic acid (152) (10 µL, 10 mM, MeCN), was added to a mixture of MeCN
(190 µL) and ammonium acetate buffer (800 µL, 50 mM, pH 8.5) in a closed 2 mL
screw-cap vial. The sample composition was analysed by HPLC at 254 nM over 48
hours.
Again, 4-thiobenzoic acid (152) (10 µL, 10 mM, MeCN), and ethacrynic acid (73) (5
µL, 10 mM, MeCN) and were added to a mixture of MeCN (185 µL) and ammonium
acetate buffer (800 µL, 50 mM, pH 8.5) in 2 mL screw-cap vial. The sample
composition was analysed by HPLC at 254 nM over 48 hours.
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Summary and Outlook
Dynamic combinatorial chemistry (DCC) is a unique approach to studying protein-
ligand interactions which integrates the synthesis and screening of small molecule
libraries into a single step. It achieves this by using reversible reactions to generate
dynamic libraries that respond to template effects. The range of reversible reactions
that can be used with biopolymer templates is limited, given that the thermodynamic
criterion of reversibility has to be met under physiological conditions which preserve
the structural and functional integrity of the template. A general research direction to
establish DCC as a preferred tool in drug discovery is the development of new
reversible chemistries which are compatible with biological targets.
In this thesis we have adopted a new strategy: using non-biological catalysts to
extend the list of reversible reactions that can form adaptive DCLs under
biocompatible conditions. Using Dawson’s simple organocatalyst, aniline, we have
generated adaptive acylhydrazone libraries that amplify isoform-specific inhibitors
for two different GST enzymes.  The molecular basis of this observed isoform-
selectivity is not well understood and requires structural studies of the protein-ligand
complexes. The protein-template induced amplification of a specific constituent of a
DCL reflects not only the binding affinity of the selected member for the template,
but also, in a very complex fashion, the affinities of all other members in the
dynamic library. Our understanding of these thermodynamic minima and
amplification effects at a systems level in biological DCLs is very preliminary at the
current stage and has substantial scope for future research. To establish broad
applicability of our approach in a drug discovery context, current projects in the
Greaney group focus on using DCC to study more challenging protein-protein and
protein- nucleic acid interactions. An immediate extension of our work currently
underway uses aniline- catalysed bis acylhydrazone DCLs to identify bivalent
inhibitors of GST.
In Chapter 3 of this thesis, we have established that thiol conjugate addition and
hydrazone formation exhibit very high levels of orthogonality when combined in a
single DCC experiment. The DCLs are formed in aqueous solution and are easily
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controlled by simple pH change, undergoing cyclical de- and re-activation according
to pH regime.
The field of DCC provides an entry into the nascent field of systems chemistry,
defined as a study of complex molecular networks. Orthogonal reversible chemistries
can be used to design oscillatory molecular networks which may serve as synthetic
mimics of metabolic and gene regulatory circuits. Simultaneous multi-level dynamic
libraries using multiple reversible reactions in a single system offer tremendous
scope for generating newer network topologies. Enmeshing the principles of network
science with complex molecular mixtures would be a giant step towards realising
‘minimal synthetic cells’ which will play a role in understanding the mysteries of cell
biology.
